vignette,question_1,question_2,question_3,question_4,question_5,answer_1,answer_2,answer_3,answer_4,answer_5,marks_1,marks_2,marks_3,marks_4,marks_5,Total_Marks_Achieved
" History of Present Illness
A 58-year-old male presents with a 3-week history of gradually worsening fatigue, weight loss, and fever. Over the past week, he has developed pain and redness in his right hand, which has been intermittently swollen. He denies trauma or any recent infections. He also reports having had bilateral leg pain that worsens with activity but improves with rest. The patient has no history of similar symptoms. He has not been on any new medications, and he denies smoking or alcohol use. His family history is notable for autoimmune diseases, as his father has rheumatoid arthritis. 

  Past Medical History
The patient has a history of hypertension for 10 years, managed with an ACE inhibitor. He has no known history of autoimmune diseases or vasculitis. He underwent a cholecystectomy 5 years ago . 

  Physical Examination
VITALS: BP 135/85 mmHg, pulse 88 bpm, temperature 100.4°F. 
GEN: Ill-appearing, mildly febrile, visibly fatigued. 
CARDIAC: Regular rhythm, no murmurs, Feeble peripheral pulses 
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender, no hepatosplenomegaly. 
MSK: Swelling and erythema of the right hand with tenderness to palpation at the metacarpophalangeal joint. Bilateral calf tenderness with no signs of deep venous thrombosis. 
EXT: No edema, but marked tenderness in the lower extremities. 
SKIN: Petechial rash over the anterior shin. 

  Laboratory Results
WBC: 12 x 103 cells/μL (elevated). Hemoglobin: 11.8 g/dL. ESR: 65 mm/h (elevated). Positive anti-ds DNA antibodies. CRP: 45 mg/L (elevated). Urinalysis: 2+ protein, no blood. Creatinine: 1.2 mg/dL.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are three possible diagnoses:

1. **Systemic Lupus Erythematosus (SLE)**: The patient's symptoms of fatigue, weight loss, fever, and joint pain, along with laboratory results showing elevated ESR, positive anti-dsDNA antibodies, and proteinuria, are consistent with SLE. The presence of a petechial rash on the anterior shin also supports this diagnosis.

2. **Rheumatoid Arthritis (RA)**: The patient's symptoms of joint pain and swelling, particularly in the hands, along with laboratory results showing elevated ESR and CRP, are consistent with RA. However, the presence of systemic symptoms such as fever and fatigue, as well as the positive anti-dsDNA antibodies, suggest a more systemic disease process.

3. **Polyarteritis Nodosa (PAN)**: The patient's symptoms of fatigue, weight loss, fever, and joint pain, along with laboratory results showing elevated ESR and CRP, are consistent with PAN. The presence of petechial rash and calf tenderness also supports this diagnosis. However, the absence of specific laboratory tests such as ANCA or anti-GBM antibodies makes this diagnosis less likely.

It's worth noting that these diagnoses are not mutually exclusive, and the patient may have a combination of these conditions or another underlying disease process. Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms.","Here are the findings and risk factors that support each possible diagnosis:

**Systemic Lupus Erythematosus (SLE)**

1. **Positive anti-dsDNA antibodies**: This is a specific autoantibody associated with SLE, and its presence strongly supports this diagnosis.
2. **Elevated ESR and CRP**: These laboratory results indicate inflammation, which is a hallmark of SLE.
3. **Proteinuria**: The presence of protein in the urine is a common finding in SLE, particularly in patients with renal involvement.
4. **Petechial rash**: This type of rash is often seen in SLE, particularly on the extremities.
5. **Family history of autoimmune diseases**: The patient's father has rheumatoid arthritis, which increases the risk of developing an autoimmune disease like SLE.
6. **Symptoms of fatigue, weight loss, and fever**: These systemic symptoms are common in SLE and can be caused by the disease process itself or by the use of medications.

**Rheumatoid Arthritis (RA)**

1. **Swelling and erythema of the right hand**: This finding is consistent with RA, particularly in the metacarpophalangeal joint.
2. **Elevated ESR and CRP**: These laboratory results indicate inflammation, which is a hallmark of RA.
3. **Bilateral calf tenderness**: This finding can be seen in RA, particularly in patients with peripheral joint involvement.
4. **Family history of autoimmune diseases**: The patient's father has rheumatoid arthritis, which increases the risk of developing RA.
5. **Symptoms of joint pain and stiffness**: These symptoms are common in RA and can be caused by the disease process itself or by the use of medications.

**Polyarteritis Nodosa (PAN)**

1. **Petechial rash**: This type of rash is often seen in PAN, particularly on the extremities.
2. **Calf tenderness**: This finding can be seen in PAN, particularly in patients with vasculitis of the lower extremities.
3. **Elevated ESR and CRP**: These laboratory results indicate inflammation, which is a hallmark of PAN.
4. **Symptoms of fatigue, weight loss, and fever**: These systemic symptoms are common in PAN and can be caused by the disease process itself or by the use of medications.
5. **Absence of specific laboratory tests**: The absence of specific laboratory tests such as ANCA or anti-GBM antibodies makes PAN a less likely diagnosis, but it is still possible in the absence of these tests.

It's worth noting that these findings and risk factors are not exclusive to each diagnosis, and the patient may have a combination of these conditions or another underlying disease process. Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms.","Here are the findings that oppose each possible diagnosis or were expected but not present:

**Systemic Lupus Erythematosus (SLE)**

1. **Absence of characteristic skin lesions**: While the patient has a petechial rash, SLE is often associated with characteristic skin lesions such as a ""butterfly"" rash on the face or discoid lesions on the skin.
2. **No mention of neurological symptoms**: SLE can cause a wide range of neurological symptoms, including seizures, psychosis, and neuropathy. The absence of these symptoms makes SLE less likely.
3. **No mention of renal failure**: SLE can cause renal failure, which is a common complication of the disease. The patient's creatinine level is only slightly elevated, which makes SLE less likely.
4. **No mention of serositis**: SLE can cause serositis, which is inflammation of the lining of the lungs, heart, or other organs. The absence of this symptom makes SLE less likely.
5. **Normal urinalysis**: While the patient has proteinuria, a normal urinalysis would make SLE less likely.

**Rheumatoid Arthritis (RA)**

1. **Absence of morning stiffness**: Morning stiffness is a common symptom of RA, and its absence makes the diagnosis less likely.
2. **No mention of symmetric joint involvement**: RA typically causes symmetric joint involvement, with both sides of the body affected equally. The patient's symptoms are limited to the right hand, which makes RA less likely.
3. **No mention of rheumatoid factor**: Rheumatoid factor is an antibody that is often present in RA. The absence of this antibody makes RA less likely.
4. **No mention of joint deformities**: RA can cause joint deformities, such as ulnar deviation or swan neck deformity. The absence of these deformities makes RA less likely.
5. **Normal ESR and CRP**: While the patient has elevated ESR and CRP, normal levels would make RA less likely.

**Polyarteritis Nodosa (PAN)**

1. **No mention of hypertension**: PAN can cause hypertension, which is a common complication of the disease. The patient's blood pressure is only mildly elevated, which makes PAN less likely.
2. **No mention of renal involvement**: PAN can cause renal involvement, including kidney failure and proteinuria. The patient's creatinine level is only slightly elevated, which makes PAN less likely.
3. **No mention of gastrointestinal symptoms**: PAN can cause gastrointestinal symptoms, including abdominal pain and weight loss. The absence of these symptoms makes PAN less likely.
4. **No mention of cardiac involvement**: PAN can cause cardiac involvement, including myocarditis and pericarditis. The absence of these symptoms makes PAN less likely.
5. **Normal urinalysis**: While the patient has proteinuria, a normal urinalysis would make PAN less likely.

It's worth noting that these findings and opposing diagnoses are not definitive and should be considered in conjunction with other clinical and laboratory findings. Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms.","Based on the patient's symptoms, laboratory results, and the findings that support and oppose each possible diagnosis, I would make the following final diagnosis:

**Systemic Lupus Erythematosus (SLE)**

The patient's symptoms of fatigue, weight loss, fever, and joint pain, along with laboratory results showing elevated ESR, positive anti-dsDNA antibodies, and proteinuria, are consistent with SLE. The presence of a petechial rash on the anterior shin also supports this diagnosis. While the patient's creatinine level is only slightly elevated, this is not uncommon in SLE, and the patient's symptoms and laboratory results are otherwise consistent with the disease.

The findings that oppose SLE, such as the absence of characteristic skin lesions and neurological symptoms, are not definitive and do not rule out the diagnosis. The patient's symptoms and laboratory results are consistent with SLE, and further testing and evaluation are not necessary to confirm the diagnosis.

**Treatment Plan**

The patient will be started on a treatment plan for SLE, which will include:

1. **Prednisone**: The patient will be started on prednisone 1 mg/kg/day to reduce inflammation and control symptoms.
2. **Hydroxychloroquine**: The patient will be started on hydroxychloroquine 200 mg twice daily to reduce inflammation and prevent disease flare-ups.
3. **Azathioprine**: The patient will be started on azathioprine 50 mg twice daily to reduce inflammation and prevent disease flare-ups.
4. **Regular follow-up**: The patient will be seen regularly to monitor symptoms, laboratory results, and disease activity.

**Monitoring**

The patient will be monitored regularly for:

1. **Symptoms**: The patient will be asked to report any changes in symptoms, including fatigue, joint pain, and fever.
2. **Laboratory results**: The patient's laboratory results will be monitored regularly to ensure that the disease is under control.
3. **Disease activity**: The patient's disease activity will be monitored regularly to ensure that the treatment plan is effective.

**Follow-up**

The patient will be seen in follow-up in 2 weeks to monitor symptoms and laboratory results. The patient will be seen every 4-6 weeks thereafter to monitor disease activity and adjust the treatment plan as necessary.","Based on the patient's diagnosis of Systemic Lupus Erythematosus (SLE), the following additional steps should be taken:

**Immunosuppressive Therapy**

1. **Monitor liver function tests (LFTs)**: Regular monitoring of LFTs is necessary to ensure that the patient's liver function is not affected by the immunosuppressive therapy.
2. **Monitor complete blood count (CBC)**: Regular monitoring of the CBC is necessary to ensure that the patient's blood cell counts are not affected by the immunosuppressive therapy.
3. **Monitor renal function**: Regular monitoring of the patient's renal function is necessary to ensure that the disease is not affecting the kidneys.

**Infection Prevention**

1. **Vaccination**: The patient should be vaccinated against influenza and pneumococcal disease to prevent infections.
2. **Antibiotic prophylaxis**: The patient may require antibiotic prophylaxis to prevent infections, particularly if they have a history of recurrent infections.
3. **Regular dental care**: Regular dental care is necessary to prevent oral infections.

**Cardiovascular Risk Reduction**

1. **Blood pressure monitoring**: Regular monitoring of the patient's blood pressure is necessary to ensure that it is under control.
2. **Lipid profile monitoring**: Regular monitoring of the patient's lipid profile is necessary to ensure that it is under control.
3. **Statins**: The patient may require statins to reduce their cardiovascular risk.

**Pregnancy Planning**

1. **Counseling**: The patient should be counseled about the risks of pregnancy in SLE and the importance of planning for pregnancy.
2. **Folic acid supplementation**: The patient should be advised to take folic acid supplements to reduce the risk of birth defects.
3. **Regular monitoring**: Regular monitoring of the patient's disease activity and renal function is necessary to ensure that the disease is under control during pregnancy.

**Psychological Support**

1. **Counseling**: The patient should be offered counseling to help them cope with the emotional and psychological impact of SLE.
2. **Support groups**: The patient should be encouraged to join a support group to connect with others who have SLE.
3. **Regular follow-up**: Regular follow-up with a mental health professional is necessary to ensure that the patient's mental health is under control.

**Other**

1. **Regular follow-up**: Regular follow-up with a rheumatologist is necessary to ensure that the patient's disease is under control.
2. **Disease activity monitoring**: Regular monitoring of the patient's disease activity is necessary to ensure that the treatment plan is effective.
3. **Adjustment of treatment plan**: The treatment plan should be adjusted as necessary to ensure that the patient's disease is under control.","{""Score"":3,""Rationale"":""Student listed SLE, RA, and Polyarteritis Nodosa, matching the three required diagnoses in the rubric.""}","{""Score"":6,""Rationale"":""The answer includes all key concepts from the high‑scoring example for Systemic Lupus Erythematosus (positive anti‑dsDNA, fatigue/weight loss/fever, elevated ESR/CRP, petechial rash, family history), Rheumatoid Arthritis (right‑hand swelling/tenderness and family history), and Vasculitis (fever, weight loss, rash). These match the rubric items worth 2 points each, giving the full 6 points.""}","{""Score"":4,""Rationale"":""Student correctly identified the key rubric points for SLE (absence of characteristic skin lesions/butterfly rash and lack of renal involvement) and for RA (absence of morning stiffness and joint deformities), earning 2 points each. No matching rubric concepts were provided for vasculitis (or peripheral vascular disease), so no points were awarded for those sections.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Systemic Lupus Erythematosus (SLE) and lists supporting clinical findings (fever, weight loss, elevated ESR, rash, proteinuria) that match the high‑scoring example, thus earning full credit.""}","{""Score"":2,""Rationale"":""The answer includes involvement of a rheumatologist (regular follow‑up), matching the referral item, but does not mention kidney biopsy or hydroxychloroquine, so only 2 of the 6 possible points are earned.""}",17.0
"History of Present Illness 
A 58-year-old male presents with a 6-month history of progressive fatigue, weight loss, and peripheral edema. He also reports shortness of breath on exertion and difficulty swallowing solid foods for the past 2 months. His urine has become frothy, and he has noticed some tingling sensations in his hands. He denies chest pain, fever, or night sweats. There is no history of hypertension, diabetes, or known heart disease. 
Past Medical History 
The patient has a 10-year history of rheumatoid arthritis, well-controlled with methotrexate. He denies smoking or alcohol use. Family history is negative for any genetic disorders. 
Physical Examination 
VITALS: BP 110/70 mmHg, pulse 90/min, temperature 98.4°F. 
GEN: Thin, pale, fatigued. 
CARDIAC: No murmurs, but there is a slight periorbital edema. 
PULM: Clear to auscultation bilaterally. 
ABD: Mild hepatomegaly (2 cm below the costal margin), no tenderness. 
EXT: Bilateral pedal edema, no erythema or ulcers. 
NEURO: Decreased sensation to light touch in both feet, absent ankle reflexes. 

Laboratory Results
Urinalysis shows 2+ proteinuria, and serum creatinine is 1.5 mg/dL. The BNP is elevated at 550 pg/mL. Serum free light chains are elevated, and a biopsy of abdominal fat reveals amyloid deposits. Echocardiogram shows concentric left ventricular hypertrophy with normal systolic function. Hemoglobin levels within normal range.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are three possible diagnoses:

1. **Amyloid Light-Chain (AL) Amyloidosis**: This is a type of amyloidosis caused by the deposition of light-chain proteins produced by plasma cells. The patient's history of rheumatoid arthritis, elevated serum free light chains, and biopsy findings of amyloid deposits in abdominal fat are consistent with this diagnosis. The presence of proteinuria, nephrotic syndrome, and congestive heart failure symptoms also support this diagnosis.

2. **Cardiac Amyloidosis (AL or Transthyretin Amyloidosis)**: The patient's symptoms of shortness of breath, peripheral edema, and elevated BNP levels suggest cardiac involvement. The echocardiogram findings of concentric left ventricular hypertrophy with normal systolic function are also consistent with cardiac amyloidosis. The patient's history of rheumatoid arthritis and elevated serum free light chains may suggest AL amyloidosis, but transthyretin amyloidosis cannot be ruled out without further testing.

3. **Nephrotic Syndrome due to Focal Segmental Glomerulosclerosis (FSGS) or other causes**: The patient's symptoms of proteinuria, peripheral edema, and weight loss could be due to nephrotic syndrome caused by FSGS or other glomerular diseases. However, the presence of amyloid deposits in abdominal fat and elevated serum free light chains suggest a systemic disease process, making this diagnosis less likely.

It is essential to note that these diagnoses are not mutually exclusive, and the patient may have a combination of these conditions. Further testing, including immunofixation electrophoresis, bone marrow biopsy, and genetic testing, may be necessary to confirm the diagnosis.","Here are the findings and risk factors supporting each possible diagnosis:

**Amyloid Light-Chain (AL) Amyloidosis**

1. **History of Rheumatoid Arthritis**: The patient has a 10-year history of rheumatoid arthritis, which is a known risk factor for developing AL amyloidosis. Rheumatoid arthritis can lead to the production of abnormal plasma cells that produce light-chain proteins, which can deposit in tissues and cause amyloidosis.
2. **Elevated Serum Free Light Chains**: The patient's serum free light chains are elevated, which is a hallmark of AL amyloidosis. This suggests that the patient's plasma cells are producing abnormal light-chain proteins that are being deposited in tissues.
3. **Biopsy Findings of Amyloid Deposits**: The biopsy of abdominal fat reveals amyloid deposits, which is a definitive finding of amyloidosis.
4. **Proteinuria and Nephrotic Syndrome**: The patient's proteinuria and nephrotic syndrome are consistent with renal involvement in AL amyloidosis.
5. **Cardiac Involvement**: The patient's symptoms of shortness of breath and elevated BNP levels suggest cardiac involvement, which is a common feature of AL amyloidosis.

**Cardiac Amyloidosis (AL or Transthyretin Amyloidosis)**

1. **Echocardiogram Findings**: The echocardiogram shows concentric left ventricular hypertrophy with normal systolic function, which is a characteristic finding of cardiac amyloidosis.
2. **Elevated BNP Levels**: The patient's elevated BNP levels suggest cardiac involvement and are consistent with cardiac amyloidosis.
3. **Symptoms of Shortness of Breath and Peripheral Edema**: The patient's symptoms of shortness of breath and peripheral edema are consistent with cardiac involvement and are common features of cardiac amyloidosis.
4. **Family History**: Although the patient denies a family history of genetic disorders, transthyretin amyloidosis can be inherited in an autosomal dominant pattern, and a family history may not be apparent.
5. **Age and Sex**: The patient's age (58 years) and sex (male) are consistent with the demographic characteristics of patients with cardiac amyloidosis.

**Nephrotic Syndrome due to Focal Segmental Glomerulosclerosis (FSGS) or other causes**

1. **Proteinuria and Nephrotic Syndrome**: The patient's proteinuria and nephrotic syndrome are consistent with renal involvement in FSGS or other glomerular diseases.
2. **Hemoglobin Levels**: The patient's hemoglobin levels are within normal range, which is consistent with FSGS or other glomerular diseases.
3. **Absence of Amyloid Deposits**: The absence of amyloid deposits in the biopsy of abdominal fat makes FSGS or other glomerular diseases more likely.
4. **No History of Hypertension or Diabetes**: The patient denies a history of hypertension or diabetes, which are common risk factors for FSGS.
5. **Normal Serum Creatinine**: The patient's serum creatinine is normal, which is consistent with FSGS or other glomerular diseases.

It is essential to note that these findings and risk factors are not exhaustive, and further testing may be necessary to confirm the diagnosis.","Here are the findings opposing each possible diagnosis:

**Amyloid Light-Chain (AL) Amyloidosis**

1. **Absence of Bone Marrow Plasmacytosis**: AL amyloidosis is typically associated with bone marrow plasmacytosis, which is the proliferation of plasma cells in the bone marrow. However, the patient's bone marrow biopsy is not mentioned, and the absence of this finding makes AL amyloidosis less likely.
2. **Normal Serum Immunoglobulin Levels**: AL amyloidosis is often associated with elevated serum immunoglobulin levels, particularly IgG and IgA. However, the patient's serum immunoglobulin levels are not mentioned, and the absence of this finding makes AL amyloidosis less likely.
3. **No History of Multiple Myeloma**: AL amyloidosis is often associated with multiple myeloma, a type of plasma cell malignancy. However, the patient denies a history of multiple myeloma, which makes AL amyloidosis less likely.
4. **Normal ECG**: AL amyloidosis can cause cardiac involvement, including conduction abnormalities and arrhythmias. However, the patient's ECG is not mentioned, and the absence of this finding makes cardiac involvement less likely.
5. **No Family History of Amyloidosis**: AL amyloidosis can be inherited in an autosomal dominant pattern, and a family history may be present. However, the patient denies a family history of amyloidosis, which makes AL amyloidosis less likely.

**Cardiac Amyloidosis (AL or Transthyretin Amyloidosis)**

1. **Normal Serum Creatinine**: Cardiac amyloidosis can cause renal involvement, including proteinuria and elevated serum creatinine. However, the patient's serum creatinine is normal, which makes cardiac amyloidosis less likely.
2. **No History of Hypertension**: Cardiac amyloidosis can cause cardiac hypertrophy and fibrosis, which can lead to hypertension. However, the patient denies a history of hypertension, which makes cardiac amyloidosis less likely.
3. **Normal Echocardiogram**: Cardiac amyloidosis can cause cardiac involvement, including left ventricular hypertrophy and diastolic dysfunction. However, the patient's echocardiogram is normal, which makes cardiac amyloidosis less likely.
4. **No Family History of Transthyretin Amyloidosis**: Transthyretin amyloidosis can be inherited in an autosomal dominant pattern, and a family history may be present. However, the patient denies a family history of transthyretin amyloidosis, which makes this diagnosis less likely.
5. **No History of Chronic Kidney Disease**: Cardiac amyloidosis can cause renal involvement, including chronic kidney disease. However, the patient denies a history of chronic kidney disease, which makes cardiac amyloidosis less likely.

**Nephrotic Syndrome due to Focal Segmental Glomerulosclerosis (FSGS) or other causes**

1. **Presence of Amyloid Deposits**: FSGS is a primary glomerular disease that does not typically cause amyloid deposits. However, the patient's biopsy of abdominal fat reveals amyloid deposits, which makes FSGS less likely.
2. **Elevated Serum Free Light Chains**: FSGS is not typically associated with elevated serum free light chains, which are a hallmark of AL amyloidosis. However, the patient's serum free light chains are elevated, which makes FSGS less likely.
3. **No History of Hypertension or Diabetes**: FSGS is often associated with hypertension and diabetes, which are common risk factors for this disease. However, the patient denies a history of hypertension or diabetes, which makes FSGS less likely.
4. **Normal Serum Creatinine**: FSGS can cause renal involvement, including proteinuria and elevated serum creatinine. However, the patient's serum creatinine is normal, which makes FSGS less likely.
5. **No Family History of FSGS**: FSGS can be inherited in an autosomal dominant pattern, and a family history may be present. However, the patient denies a family history of FSGS, which makes this diagnosis less likely.","Based on the patient's symptoms, laboratory results, and physical examination findings, the final diagnosis is:

**Amyloid Light-Chain (AL) Amyloidosis**

The patient's history of rheumatoid arthritis, elevated serum free light chains, and biopsy findings of amyloid deposits in abdominal fat are consistent with AL amyloidosis. The presence of proteinuria, nephrotic syndrome, and congestive heart failure symptoms also support this diagnosis.

The patient's symptoms of shortness of breath, peripheral edema, and elevated BNP levels suggest cardiac involvement, which is a common feature of AL amyloidosis. The echocardiogram findings of concentric left ventricular hypertrophy with normal systolic function are also consistent with cardiac amyloidosis.

The absence of bone marrow plasmacytosis, normal serum immunoglobulin levels, and no history of multiple myeloma make AL amyloidosis less likely, but the presence of amyloid deposits and elevated serum free light chains make this diagnosis more likely.

The patient's age (58 years) and sex (male) are consistent with the demographic characteristics of patients with AL amyloidosis.

**Treatment Plan**

The patient will require a multidisciplinary approach to manage AL amyloidosis, including:

1. **Chemotherapy**: The patient will require chemotherapy to reduce the production of abnormal plasma cells and decrease the deposition of amyloid proteins.
2. **Supportive Care**: The patient will require supportive care, including diuretics, ACE inhibitors, and beta-blockers to manage cardiac symptoms and prevent progression of cardiac disease.
3. **Dialysis**: The patient may require dialysis to manage renal failure and prevent progression of kidney disease.
4. **Monitoring**: The patient will require regular monitoring of serum free light chains, serum creatinine, and cardiac function to assess response to treatment and adjust therapy as needed.

**Prognosis**

The prognosis for patients with AL amyloidosis is generally poor, with a median survival of 1-2 years. However, with aggressive treatment and supportive care, some patients may experience improved symptoms and prolonged survival.","Based on the final diagnosis of Amyloid Light-Chain (AL) Amyloidosis, the following additional steps should be taken:

**Immediate Steps**

1. **Bone Marrow Biopsy**: A bone marrow biopsy should be performed to assess the extent of plasma cell proliferation and to identify any clonal plasma cell populations.
2. **Immunofixation Electrophoresis**: Immunofixation electrophoresis should be performed to identify the type of light chain (kappa or lambda) and to assess the level of monoclonal protein production.
3. **Serum Free Light Chain Assay**: A serum free light chain assay should be performed to assess the level of free light chain production and to monitor response to treatment.
4. **Cardiac Evaluation**: A cardiac evaluation should be performed to assess the extent of cardiac involvement and to monitor response to treatment.

**Short-Term Steps (within 1-2 weeks)**

1. **Start Chemotherapy**: Chemotherapy should be started to reduce the production of abnormal plasma cells and to decrease the deposition of amyloid proteins.
2. **Start Supportive Care**: Supportive care, including diuretics, ACE inhibitors, and beta-blockers, should be started to manage cardiac symptoms and prevent progression of cardiac disease.
3. **Monitor Renal Function**: Renal function should be monitored closely to assess the extent of renal involvement and to adjust treatment as needed.

**Long-Term Steps (within 1-3 months)**

1. **Repeat Bone Marrow Biopsy**: A repeat bone marrow biopsy should be performed to assess the response to chemotherapy and to identify any changes in plasma cell proliferation.
2. **Repeat Immunofixation Electrophoresis**: Immunofixation electrophoresis should be repeated to assess the response to chemotherapy and to identify any changes in monoclonal protein production.
3. **Repeat Serum Free Light Chain Assay**: A repeat serum free light chain assay should be performed to assess the response to chemotherapy and to monitor for any changes in free light chain production.
4. **Monitor Cardiac Function**: Cardiac function should be monitored closely to assess the response to treatment and to adjust therapy as needed.

**Ongoing Monitoring**

1. **Regular Follow-Up**: Regular follow-up appointments should be scheduled to monitor the patient's response to treatment and to adjust therapy as needed.
2. **Regular Laboratory Tests**: Regular laboratory tests, including serum free light chain assay, immunofixation electrophoresis, and renal function tests, should be performed to monitor the patient's response to treatment.
3. **Regular Cardiac Evaluation**: Regular cardiac evaluation should be performed to monitor the patient's cardiac function and to adjust therapy as needed.","{""Score"":1,""Rationale"":""The answer includes Amyloidosis, which matches a high‑scoring concept (1 mark). It does not mention Congestive Cardiac Failure, Chronic Kidney Disease, or Multiple Myeloma, so no additional points are awarded.""}","{""Score"":2,""Rationale"":""The answer includes the amyloidosis diagnosis matching the rubric (2 points). It does not explicitly identify congestive cardiac failure, chronic kidney disease, or multiple myeloma as listed, so no points for those categories.""}","{""Score"":2,""Rationale"":""The answer only includes the concept of amyloidosis (AL amyloidosis), which matches one of the high‑scoring concepts. It does not address Congestive Cardiac Failure, Chronic Kidney Disease, or amyloid deposition related to multiple myeloma, so no points are awarded for those items.""}","{""Score"":2,""Rationale"":""Student correctly identified amyloidosis (AL amyloidosis) with supporting clinical and biopsy findings, matching the high‑scoring example.""}","{""Score"":2,""Rationale"":""The answer includes a bone marrow biopsy, which matches one of the three required items. It does not mention a cardiac MRI or a renal biopsy, so only 2 of the 6 possible points are earned.""}",9.0
"History of Present Illness
A 59-year-old male presents with swelling and pain in his right leg that started 3 days ago. He was discharged from the hospital 2 weeks ago after undergoing knee replacement surgery, during which he received prophylactic low molecular weight heparin. He reports intermittent fever and recent episodes of palpitations. He denies chest pain, shortness of breath, or prior deep vein thrombosis (DVT). 

  Past Medical History
He has a history of osteoarthritis requiring knee replacement. He has hypertension, controlled with amlodipine, and a history of dyslipidemia. He has no history of malignancy or clotting disorders. 

  Physical Examination
VITALS: BP 125/80 mmHg, pulse 102/min, temperature 99.6°F. 
GEN: Appears mildly uncomfortable. 
CARDIAC: Regular rhythm, no murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender. 
EXT: Right leg swollen with mild erythema and tenderness along the femoral vein. Homans' sign is positive. No ulcers or skin changes. 
SKIN: Petechiae on both forearms. 

  Laboratory Results
Platelet count has decreased to 58 x 10³/μL from 210 x 10³/μL 10 days ago. D-dimer is elevated at 5.2 μg/mL. The Heparin-PF4 antibody test is positive. Ultrasound reveals a thrombus in the right femoral vein.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation and laboratory results, here are three possible diagnoses:

1. **Heparin-Induced Thrombocytopenia (HIT)**: This is a serious complication of heparin therapy, characterized by a decrease in platelet count and the formation of antibodies against the heparin-PF4 complex. The patient's history of recent heparin use, positive heparin-PF4 antibody test, and thrombocytopenia are consistent with HIT.

2. **Deep Vein Thrombosis (DVT) with Thrombocytopenia**: The patient's symptoms of swelling, pain, and erythema in the right leg, along with the ultrasound findings of a thrombus in the right femoral vein, suggest a DVT. The thrombocytopenia could be a secondary effect of the DVT or another underlying condition.

3. **Immune Thrombocytopenia (ITP)**: Although less likely, ITP is a possibility, given the patient's thrombocytopenia and the presence of petechiae on the forearms. However, the patient's recent history of heparin use and the positive heparin-PF4 antibody test make HIT a more likely diagnosis.

It's essential to note that HIT is a medical emergency, and prompt diagnosis and treatment are crucial to prevent further complications.","Here are the findings and risk factors supporting each possible diagnosis:

**Heparin-Induced Thrombocytopenia (HIT)**

1. **Recent heparin use**: The patient was discharged from the hospital 2 weeks ago after undergoing knee replacement surgery, during which he received prophylactic low molecular weight heparin.
2. **Positive heparin-PF4 antibody test**: This is a specific test for HIT, and a positive result indicates the presence of antibodies against the heparin-PF4 complex.
3. **Thrombocytopenia**: The patient's platelet count has decreased significantly from 210 x 10³/μL to 58 x 10³/μL, which is consistent with HIT.
4. **Thrombosis**: The presence of a thrombus in the right femoral vein suggests that the patient's HIT has led to the formation of a blood clot.
5. **Timing**: The patient's symptoms and laboratory results are consistent with the typical timing of HIT, which usually occurs 5-10 days after the initiation of heparin therapy.

**Deep Vein Thrombosis (DVT) with Thrombocytopenia**

1. **Swelling and pain in the right leg**: These symptoms are consistent with a DVT, and the patient's recent history of knee replacement surgery increases his risk for DVT.
2. **Ultrasound findings**: The ultrasound revealed a thrombus in the right femoral vein, which confirms the presence of a DVT.
3. **Elevated D-dimer**: The patient's D-dimer is elevated, which is a marker of thrombosis.
4. **Risk factors for DVT**: The patient's recent surgery, immobility, and history of cancer (none mentioned, but the patient has osteoarthritis) increase his risk for DVT.

**Immune Thrombocytopenia (ITP)**

1. **Petechiae on the forearms**: These are small, pinpoint bleeding spots that are consistent with ITP.
2. **Thrombocytopenia**: The patient's platelet count is significantly decreased, which is a hallmark of ITP.
3. **Absence of other risk factors**: The patient does not have any other risk factors for ITP, such as recent infection, medication use, or autoimmune disorders.

However, the presence of a positive heparin-PF4 antibody test and the patient's recent history of heparin use make HIT a more likely diagnosis.","Here are the findings opposing each possible diagnosis:

**Heparin-Induced Thrombocytopenia (HIT)**

1. **Absence of other risk factors**: HIT is more common in patients who have received unfractionated heparin or have a history of HIT. The patient's use of low molecular weight heparin and lack of prior HIT make this diagnosis less likely.
2. **No history of malignancy**: HIT is more common in patients with malignancy, particularly those with a history of cancer. The patient's lack of malignancy history makes this diagnosis less likely.
3. **No other signs of thrombosis**: While the patient has a thrombus in the right femoral vein, there is no evidence of other thromboses, such as pulmonary embolism or arterial thrombosis, which are common in HIT.
4. **No significant elevation in platelet count before thrombocytopenia**: In HIT, the platelet count often increases before decreasing, a phenomenon known as ""platelet rebound."" The patient's platelet count decreased without a preceding increase makes this diagnosis less likely.

**Deep Vein Thrombosis (DVT) with Thrombocytopenia**

1. **No other signs of DVT**: While the patient has a thrombus in the right femoral vein, there is no evidence of other signs of DVT, such as swelling, pain, or erythema in other limbs.
2. **No significant elevation in D-dimer**: While the patient's D-dimer is elevated, it is not significantly elevated, which is often seen in DVT.
3. **No history of recent surgery or trauma**: DVT is more common in patients who have recently undergone surgery or experienced trauma. The patient's recent knee replacement surgery increases his risk for DVT, but the absence of other risk factors makes this diagnosis less likely.
4. **No other risk factors for DVT**: The patient does not have any other risk factors for DVT, such as immobility, cancer, or genetic predisposition.

**Immune Thrombocytopenia (ITP)**

1. **No other signs of ITP**: While the patient has petechiae on the forearms, there is no evidence of other signs of ITP, such as purpura, ecchymoses, or bleeding gums.
2. **No significant elevation in reticulocyte count**: In ITP, the reticulocyte count often increases as the bone marrow tries to compensate for the decreased platelet count. The patient's reticulocyte count is not significantly elevated, which makes this diagnosis less likely.
3. **No history of recent infection or medication use**: ITP is more common in patients who have recently experienced an infection or have been exposed to certain medications. The patient's lack of these risk factors makes this diagnosis less likely.
4. **No other autoimmune disorders**: ITP is often associated with other autoimmune disorders, such as autoimmune hemolytic anemia or rheumatoid arthritis. The patient does not have any other autoimmune disorders, which makes this diagnosis less likely.","Based on the patient's presentation, laboratory results, and the findings supporting and opposing each possible diagnosis, I would make the following final diagnosis:

**Heparin-Induced Thrombocytopenia (HIT)**

The patient's recent history of heparin use, positive heparin-PF4 antibody test, thrombocytopenia, and thrombosis in the right femoral vein are all consistent with HIT. While there are some findings that oppose this diagnosis, such as the absence of other risk factors and the lack of significant elevation in platelet count before thrombocytopenia, the overall evidence points towards HIT as the most likely diagnosis.

**Reasoning:**

* The patient's recent history of heparin use and positive heparin-PF4 antibody test are strong indicators of HIT.
* The thrombocytopenia and thrombosis in the right femoral vein are consistent with HIT.
* While there are some findings that oppose this diagnosis, they are not sufficient to rule out HIT.
* The patient's symptoms and laboratory results are consistent with the typical timing and presentation of HIT.

**Management:**

* Discontinue heparin and any other anticoagulants.
* Administer alternative anticoagulants, such as argatroban or bivalirudin, to prevent further thrombosis.
* Monitor the patient's platelet count and adjust the anticoagulant therapy as needed.
* Consider further testing, such as a repeat heparin-PF4 antibody test, to confirm the diagnosis of HIT.

**Prognosis:**

* The prognosis for patients with HIT is generally good if treated promptly and appropriately.
* However, HIT can be a life-threatening condition if not recognized and treated promptly.
* The patient's outcome will depend on the severity of the thrombosis and the effectiveness of the anticoagulant therapy.","Based on the final diagnosis of Heparin-Induced Thrombocytopenia (HIT), the following additional steps should be taken:

**Immediate Steps:**

1. **Discontinue heparin and any other anticoagulants**: Immediately discontinue heparin and any other anticoagulants that the patient is receiving.
2. **Administer alternative anticoagulants**: Administer alternative anticoagulants, such as argatroban or bivalirudin, to prevent further thrombosis.
3. **Monitor the patient's platelet count**: Monitor the patient's platelet count closely to ensure that it is increasing and to adjust the anticoagulant therapy as needed.
4. **Assess the patient's risk for further thrombosis**: Assess the patient's risk for further thrombosis and consider additional testing, such as a repeat heparin-PF4 antibody test, to confirm the diagnosis of HIT.

**Short-Term Steps:**

1. **Perform a thorough evaluation of the patient's thrombosis**: Perform a thorough evaluation of the patient's thrombosis, including imaging studies, to determine the extent and location of the thrombosis.
2. **Consider thrombectomy or thrombolysis**: Consider thrombectomy or thrombolysis to remove the thrombus and restore blood flow to the affected area.
3. **Monitor the patient's renal function**: Monitor the patient's renal function closely, as HIT can cause renal failure.
4. **Consider additional testing**: Consider additional testing, such as a coagulation panel, to evaluate the patient's coagulation status.

**Long-Term Steps:**

1. **Develop a plan for long-term anticoagulation**: Develop a plan for long-term anticoagulation to prevent further thrombosis.
2. **Monitor the patient's platelet count regularly**: Monitor the patient's platelet count regularly to ensure that it remains within a safe range.
3. **Consider alternative anticoagulants**: Consider alternative anticoagulants, such as warfarin or apixaban, for long-term anticoagulation.
4. **Educate the patient and their family**: Educate the patient and their family about the risks and benefits of anticoagulant therapy and the importance of regular monitoring.

**Follow-Up:**

1. **Schedule follow-up appointments**: Schedule follow-up appointments with the patient to monitor their progress and adjust their anticoagulant therapy as needed.
2. **Monitor the patient's laboratory results**: Monitor the patient's laboratory results, including their platelet count and coagulation panel, to ensure that they are within a safe range.
3. **Assess the patient's risk for further thrombosis**: Assess the patient's risk for further thrombosis and adjust their anticoagulant therapy accordingly.","{""Score"":2,""Rationale"":""The answer includes Heparin-Induced Thrombocytopenia (HIT) and Deep Vein Thrombosis (DVT), which match two of the three rubric items. Fat embolism is not mentioned, so only 2 of 3 points are awarded.""}","{""Score"":4,""Rationale"":""The answer correctly identifies Heparin-Induced Thrombocytopenia and Deep Vein Thrombosis as in the rubric (2 points each). It does not mention Fat Embolism, instead adds Immune Thrombocytopenia, which is not in the rubric, so no points for the third item. Total 4 points.""}","{""Score"":4,""Rationale"":""Student identified HIT and DVT, which match two concepts in the rubric (2 points each). Fat Embolism, required for full credit, was omitted, and the extra ITP diagnosis is not in the rubric, so no points for it.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Heparin‑Induced Thrombocytopenia and includes the key features from the high‑scoring example (recent heparin use, positive Heparin‑PF4 antibody test, thrombocytopenia, new thrombosis), thus meeting the rubric criteria.""}","{""Score"":6,""Rationale"":""All three required actions—discontinue heparin, start alternative anticoagulation (argatroban), and closely monitor platelet count—are present, matching the high‑scoring example.""}",18.0
"History of Present Illness
A 44-year-old female presents with a 6-month history of unintentional weight gain, especially in her abdomen and face. She notes the appearance of purple striae on her abdomen and has recently developed increased acne and facial hair growth. She reports fatigue, insomnia, and mood swings. Over the last month, she has had progressive weakness in her legs, which is most noticeable when climbing stairs.

Past Medical History
The patient has a history of polycystic ovary syndrome (PCOS), for which she has been treated intermittently with oral contraceptives. She denies any history of diabetes or previous steroid use.

Physical Examination
VITALS: BP 170/110 mmHg, pulse 82/min, temperature 98.5°F.
GEN: Overweight, with moon facies and a central distribution of fat.
CARDIAC: Regular rhythm, no murmurs.
PULM: Clear to auscultation bilaterally.
ABD: Obese with prominent abdominal striae and a rounded abdomen.
EXT: Bilateral proximal muscle weakness, especially in the thighs.
SKIN: Purple striae on the abdomen, mild acne on the back and face.

Laboratory Results
Serum cortisol levels are elevated, with a 24-hour urine cortisol excretion of 500 μg/day (normal: <50 μg/day). ACTH is raised, and MRI of the pituitary gland shows a small adenoma.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are three possible diagnoses:

1. **Cushing's Syndrome**: This is a condition caused by excess cortisol levels in the body, which can be due to various reasons such as a pituitary adenoma (as seen in this patient), adrenal gland tumors, or long-term use of corticosteroid medications. The patient's symptoms, including weight gain, purple striae, acne, facial hair growth, and muscle weakness, are consistent with Cushing's syndrome.

2. **Pituitary Adenoma with Hypercortisolism**: The patient's MRI shows a small adenoma in the pituitary gland, which is secreting excess ACTH (adrenocorticotropic hormone). This leads to increased cortisol production by the adrenal glands, resulting in Cushing's syndrome.

3. **Adrenocorticotropic Hormone (ACTH)-dependent Cushing's Syndrome**: This is a type of Cushing's syndrome caused by an overproduction of ACTH by a pituitary tumor (adenoma), as seen in this patient. The elevated ACTH stimulates the adrenal glands to produce excess cortisol, leading to the symptoms of Cushing's syndrome.

These diagnoses are not mutually exclusive, and the patient's condition may be a combination of these possibilities.","Here are the findings and risk factors supporting each possible diagnosis:

**Cushing's Syndrome**

1. **Elevated serum cortisol levels**: The patient's 24-hour urine cortisol excretion of 500 μg/day is significantly higher than the normal value (<50 μg/day), indicating excess cortisol production.
2. **Purple striae**: The presence of purple striae on the abdomen is a classic sign of Cushing's syndrome, which is caused by the thinning of the skin due to excess cortisol.
3. **Weight gain and moon facies**: The patient's weight gain, particularly in the central region, and moon facies (round face) are common features of Cushing's syndrome.
4. **Acne and hirsutism**: The patient's acne and facial hair growth are also consistent with Cushing's syndrome, which is caused by the hormonal imbalance.
5. **Hypertension**: The patient's blood pressure of 170/110 mmHg is elevated, which is a common finding in Cushing's syndrome.

**Pituitary Adenoma with Hypercortisolism**

1. **MRI findings**: The patient's MRI shows a small adenoma in the pituitary gland, which is secreting excess ACTH.
2. **Elevated ACTH levels**: The patient's elevated ACTH levels are consistent with a pituitary adenoma causing hypercortisolism.
3. **Symptoms of pituitary adenoma**: The patient's symptoms, such as progressive weakness in the legs, may be related to the pituitary adenoma compressing adjacent structures.
4. **History of PCOS**: The patient's history of PCOS may be related to the pituitary adenoma, as some cases of PCOS are associated with pituitary tumors.

**Adrenocorticotropic Hormone (ACTH)-dependent Cushing's Syndrome**

1. **Elevated ACTH levels**: The patient's elevated ACTH levels are consistent with an ACTH-producing pituitary tumor.
2. **Pituitary adenoma**: The patient's MRI shows a small adenoma in the pituitary gland, which is secreting excess ACTH.
3. **Symptoms of Cushing's syndrome**: The patient's symptoms, such as weight gain, purple striae, and acne, are consistent with Cushing's syndrome caused by excess ACTH.
4. **History of PCOS**: The patient's history of PCOS may be related to the ACTH-producing pituitary tumor, as some cases of PCOS are associated with pituitary tumors.

These findings and risk factors support the diagnosis of Cushing's syndrome, pituitary adenoma with hypercortisolism, and ACTH-dependent Cushing's syndrome.","Here are the findings opposing each possible diagnosis:

**Cushing's Syndrome**

1. **Lack of adrenal gland abnormalities**: Cushing's syndrome can be caused by adrenal gland tumors or hyperplasia. However, the patient's MRI did not show any abnormalities in the adrenal glands.
2. **Normal electrolyte levels**: Cushing's syndrome can cause electrolyte imbalances, particularly hypokalemia. However, the patient's electrolyte levels were not reported.
3. **No history of steroid use**: Cushing's syndrome can be caused by long-term use of corticosteroid medications. However, the patient denied any history of steroid use.
4. **No family history of Cushing's syndrome**: Cushing's syndrome can be inherited in some cases. However, the patient's family history was not reported.
5. **Normal glucose tolerance**: Cushing's syndrome can cause glucose intolerance or diabetes. However, the patient's glucose tolerance was not reported.

**Pituitary Adenoma with Hypercortisolism**

1. **Lack of visual field defects**: Pituitary adenomas can cause visual field defects due to compression of the optic chiasm. However, the patient's visual fields were not reported.
2. **No history of headaches**: Pituitary adenomas can cause headaches due to compression of the surrounding structures. However, the patient denied any history of headaches.
3. **Normal pituitary function**: Pituitary adenomas can cause hypopituitarism. However, the patient's pituitary function was not reported.
4. **No evidence of other pituitary hormone imbalances**: Pituitary adenomas can cause imbalances in other pituitary hormones. However, the patient's hormone levels were not reported.
5. **MRI findings not typical for pituitary adenoma**: The patient's MRI showed a small adenoma in the pituitary gland, but the findings were not typical for a pituitary adenoma.

**Adrenocorticotropic Hormone (ACTH)-dependent Cushing's Syndrome**

1. **Lack of other symptoms of pituitary adenoma**: ACTH-producing pituitary tumors can cause other symptoms such as headaches, visual field defects, and hypopituitarism. However, the patient did not report these symptoms.
2. **No evidence of other pituitary hormone imbalances**: ACTH-producing pituitary tumors can cause imbalances in other pituitary hormones. However, the patient's hormone levels were not reported.
3. **Normal pituitary function**: ACTH-producing pituitary tumors can cause hypopituitarism. However, the patient's pituitary function was not reported.
4. **MRI findings not typical for ACTH-producing pituitary tumor**: The patient's MRI showed a small adenoma in the pituitary gland, but the findings were not typical for an ACTH-producing pituitary tumor.
5. **No family history of ACTH-producing pituitary tumors**: ACTH-producing pituitary tumors can be inherited in some cases. However, the patient's family history was not reported.

These findings opposing each possible diagnosis suggest that the patient's condition may not be as straightforward as initially thought, and further investigation may be necessary to determine the underlying cause of her symptoms.","Based on the patient's symptoms, laboratory results, and the findings supporting and opposing each possible diagnosis, I would make the following final diagnosis:

**Final Diagnosis: ACTH-dependent Cushing's Syndrome due to a Pituitary Adenoma**

The patient's symptoms, including weight gain, purple striae, acne, and muscle weakness, are consistent with Cushing's syndrome. The elevated serum cortisol levels and 24-hour urine cortisol excretion are also indicative of Cushing's syndrome. The patient's MRI shows a small adenoma in the pituitary gland, which is secreting excess ACTH, leading to the symptoms of Cushing's syndrome.

The findings opposing Cushing's syndrome, such as the lack of adrenal gland abnormalities and normal electrolyte levels, do not rule out the diagnosis. The patient's history of PCOS may be related to the pituitary adenoma, as some cases of PCOS are associated with pituitary tumors.

The findings opposing pituitary adenoma with hypercortisolism, such as the lack of visual field defects and normal pituitary function, do not rule out the diagnosis. The patient's MRI findings are consistent with a pituitary adenoma, and the elevated ACTH levels are indicative of an ACTH-producing pituitary tumor.

The findings opposing ACTH-dependent Cushing's syndrome, such as the lack of other symptoms of pituitary adenoma and normal pituitary function, do not rule out the diagnosis. The patient's MRI findings are consistent with a pituitary adenoma, and the elevated ACTH levels are indicative of an ACTH-producing pituitary tumor.

Therefore, based on the patient's symptoms, laboratory results, and the findings supporting and opposing each possible diagnosis, I would make the final diagnosis of ACTH-dependent Cushing's syndrome due to a pituitary adenoma.

**Treatment Plan:**

1. **Surgical resection of the pituitary adenoma**: The patient will undergo surgery to remove the pituitary adenoma.
2. **Post-operative management**: The patient will be monitored for any complications and will receive post-operative care to manage any potential side effects.
3. **Hormone replacement therapy**: The patient may require hormone replacement therapy to manage any potential deficiencies in other pituitary hormones.
4. **Follow-up appointments**: The patient will require regular follow-up appointments to monitor for any recurrence of the pituitary adenoma and to manage any potential side effects.

**Prognosis:**

The prognosis for the patient is generally good, with a high likelihood of successful surgical resection of the pituitary adenoma. However, the patient may require ongoing management to manage any potential side effects and to monitor for any recurrence of the pituitary adenoma.","Based on the final diagnosis of ACTH-dependent Cushing's syndrome due to a pituitary adenoma, the following additional steps should be taken:

**Pre-operative steps:**

1. **Imaging studies**: The patient should undergo additional imaging studies, such as a CT or MRI scan, to confirm the size and location of the pituitary adenoma.
2. **Endocrine evaluation**: The patient should undergo an endocrine evaluation to assess the function of the pituitary gland and to determine if there are any other hormone imbalances.
3. **Cardiovascular evaluation**: The patient should undergo a cardiovascular evaluation to assess the risk of cardiovascular complications during and after surgery.
4. **Neurosurgical consultation**: The patient should be referred to a neurosurgeon for a consultation to discuss the surgical approach and to determine if there are any potential risks or complications.

**Surgical steps:**

1. **Transsphenoidal surgery**: The patient should undergo transsphenoidal surgery to remove the pituitary adenoma.
2. **Intraoperative monitoring**: The patient should be monitored intraoperatively to assess the function of the pituitary gland and to determine if there are any other hormone imbalances.
3. **Post-operative care**: The patient should receive post-operative care to manage any potential complications and to monitor for any recurrence of the pituitary adenoma.

**Post-operative steps:**

1. **Hormone replacement therapy**: The patient may require hormone replacement therapy to manage any potential deficiencies in other pituitary hormones.
2. **Follow-up appointments**: The patient should have regular follow-up appointments to monitor for any recurrence of the pituitary adenoma and to manage any potential side effects.
3. **Endocrine evaluation**: The patient should undergo regular endocrine evaluations to assess the function of the pituitary gland and to determine if there are any other hormone imbalances.
4. **Cardiovascular evaluation**: The patient should undergo regular cardiovascular evaluations to assess the risk of cardiovascular complications.

**Additional considerations:**

1. **Genetic testing**: The patient may benefit from genetic testing to determine if there is a genetic component to the pituitary adenoma.
2. **Family screening**: The patient's family members may benefit from screening for pituitary adenomas and other endocrine disorders.
3. **Lifestyle modifications**: The patient should make lifestyle modifications, such as a healthy diet and regular exercise, to manage any potential side effects and to reduce the risk of recurrence.

**Timeline:**

1. **Pre-operative evaluation**: The patient should undergo pre-operative evaluation within 1-2 weeks of the scheduled surgery.
2. **Surgery**: The patient should undergo surgery within 1-2 weeks of the pre-operative evaluation.
3. **Post-operative care**: The patient should receive post-operative care for 1-2 weeks after surgery.
4. **Follow-up appointments**: The patient should have regular follow-up appointments for 6-12 months after surgery.

**Costs:**

1. **Imaging studies**: The cost of imaging studies, such as a CT or MRI scan, will depend on the specific study and the location of the patient.
2. **Endocrine evaluation**: The cost of endocrine evaluation will depend on the specific tests and the location of the patient.
3. **Cardiovascular evaluation**: The cost of cardiovascular evaluation will depend on the specific tests and the location of the patient.
4. **Surgery**: The cost of surgery will depend on the specific procedure and the location of the patient.
5. **Post-operative care**: The cost of post-operative care will depend on the specific services and the location of the patient.

**Insurance coverage:**

1. **Imaging studies**: The patient's insurance should cover the cost of imaging studies, such as a CT or MRI scan.
2. **Endocrine evaluation**: The patient's insurance should cover the cost of endocrine evaluation.
3. **Cardiovascular evaluation**: The patient's insurance should cover the cost of cardiovascular evaluation.
4. **Surgery**: The patient's insurance should cover the cost of surgery.
5. **Post-operative care**: The patient's insurance should cover the cost of post-operative care.","{""Score"":2,""Rationale"":""Student correctly identified Cushing's Syndrome (matches Cushing’s Syndrome/Exogenous Steroids) and provided a synonym for Cushing's Disease (Pituitary Adenoma with Hypercortisolism/ACTH-dependent Cushing's Syndrome). PCOS was not mentioned, so only two of the three required concepts are present.""}","{
  ""Score"": 4,
  ""Rationale"": ""The answer includes many key features of Cushing's Syndrome/Disease (elevated cortisol, elevated ACTH, weight gain, moon facies, purple striae, acne, hirsutism, hypertension, muscle weakness) matching the rubric, earning 2 points for Cushing's Disease and 2 points for Cushing's Syndrome. However, it does not address PCOS as a differential diagnosis nor mention several rubric-specific symptoms (insomnia, mood swings, proximal muscle weakness explicitly), so no points are awarded for the PCOS category.""
}","{
  ""Score"": 0,
  ""Rationale"": ""The answer does not address any of the diagnoses or opposing findings specified in the rubric (Cushing's Disease, Cushing’s Syndrome/Exogenous Steroids, PCOS). Therefore, no points are awarded.""
}","{
  ""Score"": 0,
  ""Rationale"": ""The answer includes weight gain, purple striae, elevated cortisol, and pituitary adenoma, but does not mention the ACTH suppression required by the rubric; thus it does not fully match the high‑scoring example.""
}","{""Score"":0,""Rationale"":""The answer does not mention any of the three required items from the rubric (dexamethasone suppression test, ACTH measurement, or referral to endocrinology); therefore no points are awarded.""}",6.0
"History Of Present Illness 
A 76-year-old male presents to his primary care physician with complaints of back and thigh pain lasting for 2 weeks. He reports no pain while sitting or lying down, but walking induces severe pain in his lower back, buttocks, and calves. He also feels fatigued and slightly febrile. A referring cardiologist noted recent test results, since the onset of pain, showing a new anemia and azotemia. Notably, a few days prior to the onset of his symptoms, the patient underwent coronary angioplasty, during which he received heparin for 48 hours.
Past Medical History 
Ischemic heart disease had first been diagnosed ten years earlier, at which time a coronary artery bypass procedure was done. 
Physical Examination 
VITALS: 99.6° F.; pulse was 94/min and regular; BP was 110/88 mmHg. 
GEN: Well appearing 
CARDS: There is a grade III/VI apical systolic murmur. 
PULM: Lungs are clear to auscultation bilaterally, no wheezing, or consolidations noted. 
ABD: Soft, non-tender to palpation 
MSK: He does not have tenderness of his spine or pelvis. Spinal mobility is normal, as is the mobility of his hips. Standing is painless; however, pain is experienced in his low back, buttocks and calves within a minute of feeble running in place. The pain disappears shortly after exercise is discontinued. 
EXT: Peripheral pulses were symmetrically reduced, but palpable. The neurological examination was normal. 
SKIN: Patient has a purple, red, lacy rash over his low back and buttocks. 
Laboratory 
WBC of 11.5 x 103 cells /μL; differential of 64% segs, 20% lymphocytes, 3% monocytes, 12% eosinophils and 1% basophil. The hematocrit was 28% and the platelet count was 315 x 103 /μL. The erythrocyte sedimentation rate was 99 mm/h. Urinalysis was normal except for 2+ proteinuria. Serum creatinine was 4.0 mg/dL; sodium was 145 mEq/L; potassium 4.0 mEq/L; chloride 105 mEq/L. SGOT was 27 U/L; GGT was 90 U/L; alkaline phosphatase was 153 U/L.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are three possible diagnoses:

1. **Thrombotic Thrombocytopenic Purpura (TTP)**: The patient's recent coronary angioplasty, new anemia, azotemia, and thrombocytopenia (low platelet count) could be indicative of TTP. The presence of a purple, red, lacy rash (purpura) on the patient's low back and buttocks also supports this diagnosis.

2. **Heparin-Induced Thrombocytopenia (HIT)**: The patient received heparin for 48 hours during coronary angioplasty, and now has a low platelet count. HIT is a known complication of heparin therapy, and the patient's symptoms, including the rash, could be indicative of this condition.

3. **Cholesterol Embolism Syndrome (CES)**: The patient's recent coronary angioplasty, new anemia, azotemia, and thrombocytopenia could also be indicative of CES. The presence of a purple, red, lacy rash on the patient's low back and buttocks, as well as the patient's symptoms of back and thigh pain, could be indicative of cholesterol emboli in the lower extremities.

These diagnoses are not mutually exclusive, and further testing and evaluation would be necessary to determine the underlying cause of the patient's symptoms.","Here are the findings and risk factors that support each possible diagnosis:

**Thrombotic Thrombocytopenic Purpura (TTP)**

* **Recent coronary angioplasty**: TTP can be triggered by certain medical procedures, including cardiac catheterization and angioplasty.
* **New anemia and azotemia**: TTP is characterized by microangiopathic hemolytic anemia, which can cause anemia and azotemia.
* **Thrombocytopenia (low platelet count)**: TTP is characterized by thrombocytopenia, which can be severe.
* **Purpura**: The presence of a purple, red, lacy rash (purpura) on the patient's low back and buttocks is a classic finding in TTP.
* **Elevated erythrocyte sedimentation rate (ESR)**: TTP can cause inflammation, which can lead to an elevated ESR.
* **Recent use of heparin**: Heparin can trigger TTP in some patients.

**Heparin-Induced Thrombocytopenia (HIT)**

* **Recent use of heparin**: HIT is a known complication of heparin therapy, and the patient received heparin for 48 hours during coronary angioplasty.
* **Thrombocytopenia (low platelet count)**: HIT is characterized by thrombocytopenia, which can be severe.
* **New anemia and azotemia**: HIT can cause microangiopathic hemolytic anemia, which can lead to anemia and azotemia.
* **Purpura**: The presence of a purple, red, lacy rash (purpura) on the patient's low back and buttocks is a classic finding in HIT.
* **Elevated ESR**: HIT can cause inflammation, which can lead to an elevated ESR.

**Cholesterol Embolism Syndrome (CES)**

* **Recent coronary angioplasty**: CES can be triggered by certain medical procedures, including cardiac catheterization and angioplasty.
* **New anemia and azotemia**: CES can cause microangiopathic hemolytic anemia, which can lead to anemia and azotemia.
* **Thrombocytopenia (low platelet count)**: CES can cause thrombocytopenia, which can be severe.
* **Purpura**: The presence of a purple, red, lacy rash (purpura) on the patient's low back and buttocks is a classic finding in CES.
* **Elevated ESR**: CES can cause inflammation, which can lead to an elevated ESR.
* **Reduced peripheral pulses**: CES can cause peripheral artery disease, which can lead to reduced peripheral pulses.
* **Proteinuria**: CES can cause kidney damage, which can lead to proteinuria.

These findings and risk factors support the hypothesis that the patient's symptoms are due to one of these three possible diagnoses. Further testing and evaluation would be necessary to determine the underlying cause of the patient's symptoms.","Here are the findings that oppose each possible diagnosis, or findings that were expected but not present:

**Thrombotic Thrombocytopenic Purpura (TTP)**

* **Expected but not present:**
 + **Schistocytes on peripheral smear**: TTP is characterized by the presence of schistocytes (fragmented red blood cells) on peripheral smear. However, this finding was not mentioned in the patient's laboratory results.
 + **Low fibrinogen levels**: TTP can cause low fibrinogen levels due to consumption of fibrinogen in the formation of microthrombi. However, fibrinogen levels were not mentioned in the patient's laboratory results.
* **Opposing findings:**
 + **Normal kidney function**: TTP can cause acute kidney injury, but the patient's serum creatinine level was only mildly elevated (4.0 mg/dL). This suggests that the patient's kidney function is not as severely affected as would be expected in TTP.
 + **No mention of neurological symptoms**: TTP can cause neurological symptoms such as headache, confusion, and seizures. However, the patient's neurological examination was normal, and there was no mention of neurological symptoms.

**Heparin-Induced Thrombocytopenia (HIT)**

* **Expected but not present:**
 + **Thrombosis**: HIT is characterized by the formation of antibodies that activate platelets and cause thrombosis. However, there was no mention of thrombosis in the patient's laboratory results or physical examination.
 + **High levels of anti-heparin antibodies**: HIT is characterized by the presence of high levels of anti-heparin antibodies. However, this finding was not mentioned in the patient's laboratory results.
* **Opposing findings:**
 + **Normal platelet count before heparin use**: HIT typically occurs after heparin use, and the patient's platelet count was normal before heparin use. This suggests that the patient's thrombocytopenia is not due to HIT.
 + **No mention of other HIT-related symptoms**: HIT can cause other symptoms such as fever, chills, and rash. However, the patient's symptoms were limited to back and thigh pain, and there was no mention of other HIT-related symptoms.

**Cholesterol Embolism Syndrome (CES)**

* **Expected but not present:**
 + **High levels of cholesterol crystals in urine**: CES is characterized by the presence of high levels of cholesterol crystals in urine. However, this finding was not mentioned in the patient's laboratory results.
 + **Severe kidney damage**: CES can cause severe kidney damage, but the patient's serum creatinine level was only mildly elevated (4.0 mg/dL). This suggests that the patient's kidney function is not as severely affected as would be expected in CES.
* **Opposing findings:**
 + **Normal lipid profile**: CES is characterized by the presence of high levels of cholesterol in the blood. However, the patient's lipid profile was not mentioned in the laboratory results.
 + **No mention of other CES-related symptoms**: CES can cause other symptoms such as fever, chills, and rash. However, the patient's symptoms were limited to back and thigh pain, and there was no mention of other CES-related symptoms.","Based on the patient's symptoms, laboratory results, and physical examination, I would make the following final diagnosis:

**Heparin-Induced Thrombocytopenia (HIT)**

The patient's recent use of heparin for 48 hours during coronary angioplasty, combined with the development of thrombocytopenia (low platelet count), new anemia, and azotemia, suggests that HIT is the most likely diagnosis. The presence of a purple, red, lacy rash (purpura) on the patient's low back and buttocks is also consistent with HIT.

While TTP and CES are also possible diagnoses, the patient's laboratory results and physical examination do not strongly support these diagnoses. The patient's kidney function is not as severely affected as would be expected in TTP or CES, and there is no mention of other symptoms that are typical of these conditions.

Therefore, based on the available information, I would make the final diagnosis of Heparin-Induced Thrombocytopenia (HIT).

**Treatment Plan:**

1. **Discontinue heparin**: Immediately discontinue heparin therapy to prevent further platelet activation and thrombosis.
2. **Administer alternative anticoagulant**: Switch to an alternative anticoagulant, such as argatroban or bivalirudin, to maintain anticoagulation while avoiding heparin.
3. **Monitor platelet count**: Closely monitor the patient's platelet count to ensure that it returns to normal.
4. **Manage symptoms**: Manage the patient's symptoms, including back and thigh pain, with analgesics and other supportive measures.
5. **Follow-up**: Schedule follow-up appointments to monitor the patient's progress and adjust treatment as needed.

**Prognosis:**

The prognosis for patients with HIT is generally good, with most patients recovering fully with prompt treatment. However, HIT can be a life-threatening condition if not recognized and treated promptly. Therefore, it is essential to closely monitor the patient's condition and adjust treatment as needed to prevent complications.","Based on the final diagnosis of Heparin-Induced Thrombocytopenia (HIT), the following additional steps should be taken:

**Immediate Steps:**

1. **Discontinue heparin**: Immediately discontinue heparin therapy to prevent further platelet activation and thrombosis.
2. **Administer alternative anticoagulant**: Switch to an alternative anticoagulant, such as argatroban or bivalirudin, to maintain anticoagulation while avoiding heparin.
3. **Monitor platelet count**: Closely monitor the patient's platelet count to ensure that it returns to normal.
4. **Manage symptoms**: Manage the patient's symptoms, including back and thigh pain, with analgesics and other supportive measures.

**Short-Term Steps:**

1. **Repeat laboratory tests**: Repeat laboratory tests, including platelet count, complete blood count (CBC), and coagulation studies, to monitor the patient's response to treatment.
2. **Monitor for thrombosis**: Monitor the patient for signs of thrombosis, including new or worsening symptoms, such as chest pain, shortness of breath, or leg pain.
3. **Adjust anticoagulant therapy**: Adjust anticoagulant therapy as needed to maintain optimal anticoagulation while minimizing the risk of bleeding.
4. **Manage bleeding risk**: Manage the patient's bleeding risk by closely monitoring for signs of bleeding, such as bruising, petechiae, or hematuria.

**Long-Term Steps:**

1. **Follow-up appointments**: Schedule follow-up appointments to monitor the patient's progress and adjust treatment as needed.
2. **Monitor for HIT recurrence**: Monitor the patient for signs of HIT recurrence, including new or worsening thrombocytopenia, thrombosis, or other symptoms.
3. **Consider alternative anticoagulants**: Consider alternative anticoagulants, such as direct oral anticoagulants (DOACs), for future anticoagulation needs.
4. **Educate patient and family**: Educate the patient and their family about the risks and benefits of anticoagulant therapy, as well as the importance of monitoring for HIT recurrence.

**Additional Considerations:**

1. **Consult with a hematologist**: Consult with a hematologist to discuss the patient's case and develop a comprehensive treatment plan.
2. **Consider a HIT antibody test**: Consider a HIT antibody test to confirm the diagnosis and monitor for HIT recurrence.
3. **Monitor for other complications**: Monitor the patient for other complications, such as kidney damage or cardiac complications, that may be related to HIT.","{""Score"":1,""Rationale"":""Only 'Cholesterol Embolism' matches an item in the rubric; the other two diagnoses are not listed in the high-scoring example, so they receive no points.""}","{""Score"":2,""Rationale"":""Only the cholesterol embolism diagnosis matches a concept in the rubric (worth 2 points). The other required diagnoses (acute interstitial nephritis and peripheral arterial disease) are absent, so no additional points are awarded.""}","{""Score"":0,""Rationale"":""Student only mentioned Cholesterol Embolism, but provided different expected/opposing findings that do not match any concepts listed in the high‑scoring example; other diagnoses are not in the rubric, so no points awarded.""}","{""Score"":0,""Rationale"":""The rubric expects the answer 'Cholesterol embolism' for full credit. The student's response was 'Heparin-Induced Thrombocytopenia (HIT)', which does not match any concept listed in the high scoring example, so no points are awarded.""}","{""Score"":0,""Rationale"":""The answer does not mention any of the required items from the rubric (arterial ultrasounds/ABI, urine analysis for casts/eosinophils with nephrology consult, or renal biopsy). Therefore no points are awarded.""}",3.0
"History of Present Illness
A 42-year-old male presents with chronic burning pain in his hands and feet, which has worsened over the past year. He has frequent episodes of abdominal cramping and diarrhea. He reports fatigue, decreased exercise tolerance, and intermittent difficulty with vision. He recalls a history of a similar condition in his older brother, who died from kidney failure at the age of 48. 

Past Medical History
The patient has been diagnosed with chronic kidney disease of unknown etiology. He also has a history of hearing loss and occasional headaches. There is a history of diabetes and hypertension. 

Physical Examination
VITALS: BP 150/90 mmHg, pulse 82/min, temperature 98.6°F. 
GEN: Thin, mildly fatigued. 
HEENT: Corneal opacities visible on slit lamp examination. 
CARDIAC: No murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Non-tender, hepatosplenomegaly noted. 
EXT: Angiokeratomas on the lower abdomen and upper thighs. 
SKIN: No significant rashes. 

Laboratory Results
Serum creatinine is elevated at 2.8 mg/dL. Urinalysis shows 3+ proteinuria with no red blood cells. Alpha-galactosidase A activity in plasma is significantly reduced.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are three possible diagnoses:

1. **Fabry Disease**: This is a genetic disorder caused by a deficiency of the enzyme alpha-galactosidase A, which leads to the accumulation of globotriaosylceramide (Gb3) in various tissues, including the kidneys, heart, and nervous system. The patient's reduced alpha-galactosidase A activity in plasma and the presence of angiokeratomas (small, red or purple spots on the skin) are consistent with Fabry disease. The patient's symptoms, including chronic burning pain in the hands and feet, abdominal cramping, diarrhea, fatigue, and vision difficulties, are also typical of Fabry disease.

2. **Diabetic Nephropathy**: The patient has a history of diabetes, which is a common cause of chronic kidney disease. Diabetic nephropathy can lead to proteinuria (excess protein in the urine), elevated serum creatinine, and other symptoms such as fatigue and decreased exercise tolerance.

3. **Nephropathy due to Hypertension**: The patient's history of hypertension and elevated serum creatinine suggest that his kidney disease may be related to high blood pressure. Hypertension can cause damage to the kidneys, leading to proteinuria, elevated serum creatinine, and other symptoms such as fatigue and decreased exercise tolerance.

However, considering the patient's family history of a similar condition and the presence of corneal opacities, Fabry disease is the most likely diagnosis.","Here are the findings and risk factors that support each possible diagnosis:

**Fabry Disease**

1. **Reduced alpha-galactosidase A activity**: The patient's plasma alpha-galactosidase A activity is significantly reduced, which is a hallmark of Fabry disease.
2. **Angiokeratomas**: The presence of angiokeratomas on the lower abdomen and upper thighs is a characteristic skin manifestation of Fabry disease.
3. **Corneal opacities**: The patient's corneal opacities, visible on slit lamp examination, are a common finding in Fabry disease.
4. **Family history**: The patient's older brother died from kidney failure at the age of 48, which suggests a possible genetic component to the patient's condition.
5. **Chronic burning pain**: The patient's chronic burning pain in the hands and feet is a common symptom of Fabry disease.
6. **Abdominal cramping and diarrhea**: The patient's gastrointestinal symptoms are also consistent with Fabry disease.

**Diabetic Nephropathy**

1. **History of diabetes**: The patient has a history of diabetes, which is a major risk factor for diabetic nephropathy.
2. **Elevated serum creatinine**: The patient's elevated serum creatinine suggests kidney damage, which is consistent with diabetic nephropathy.
3. **Proteinuria**: The patient's proteinuria (excess protein in the urine) is a common finding in diabetic nephropathy.
4. **Hypertension**: The patient's hypertension is a risk factor for diabetic nephropathy.

**Nephropathy due to Hypertension**

1. **Hypertension**: The patient's hypertension is a major risk factor for nephropathy.
2. **Elevated serum creatinine**: The patient's elevated serum creatinine suggests kidney damage, which is consistent with nephropathy due to hypertension.
3. **Proteinuria**: The patient's proteinuria (excess protein in the urine) is a common finding in nephropathy due to hypertension.
4. **Kidney disease of unknown etiology**: The patient's kidney disease is of unknown etiology, which could be consistent with nephropathy due to hypertension.

However, considering the patient's family history, corneal opacities, and reduced alpha-galactosidase A activity, Fabry disease is the most likely diagnosis.","Here are the findings that oppose each possible diagnosis:

**Fabry Disease**

1. **Lack of specific Fabry disease-related symptoms**: While the patient has chronic burning pain, abdominal cramping, and diarrhea, these symptoms are not specific to Fabry disease and could be caused by other conditions.
2. **No mention of cardiac involvement**: Fabry disease often causes cardiac involvement, such as hypertrophic cardiomyopathy or coronary artery disease. The patient's cardiac examination is normal, which suggests that cardiac involvement may not be present.
3. **No mention of hearing loss progression**: Fabry disease can cause progressive hearing loss, but the patient's hearing loss is not mentioned as being progressive.
4. **Normal kidney function in early stages**: Fabry disease often causes kidney damage in the early stages, but the patient's kidney disease is already advanced (elevated serum creatinine and proteinuria).
5. **No mention of gastrointestinal bleeding**: Fabry disease can cause gastrointestinal bleeding, but the patient's gastrointestinal symptoms are not mentioned as being severe enough to cause bleeding.

**Diabetic Nephropathy**

1. **Normal blood glucose levels**: The patient's blood glucose levels are not mentioned, but if they are normal, it would suggest that diabetic nephropathy is less likely.
2. **No mention of retinopathy**: Diabetic retinopathy is a common complication of diabetes, but the patient's eye examination is not mentioned as showing any signs of retinopathy.
3. **Normal kidney function in early stages**: Diabetic nephropathy often causes kidney damage in the early stages, but the patient's kidney disease is already advanced (elevated serum creatinine and proteinuria).
4. **No mention of neuropathy**: Diabetic neuropathy is a common complication of diabetes, but the patient's symptoms do not suggest neuropathy.
5. **Family history of kidney disease**: While the patient's family history of kidney disease is a risk factor for diabetic nephropathy, it is not a definitive indicator of the condition.

**Nephropathy due to Hypertension**

1. **Normal blood pressure in early stages**: Nephropathy due to hypertension often causes kidney damage in the early stages, but the patient's hypertension is not mentioned as being severe enough to cause kidney damage.
2. **No mention of proteinuria in early stages**: Nephropathy due to hypertension often causes proteinuria in the early stages, but the patient's proteinuria is already severe (3+ proteinuria).
3. **No mention of hematuria**: Nephropathy due to hypertension often causes hematuria (blood in the urine), but the patient's urinalysis does not mention hematuria.
4. **No mention of kidney size**: Nephropathy due to hypertension often causes kidney enlargement, but the patient's kidney size is not mentioned.
5. **Family history of kidney disease**: While the patient's family history of kidney disease is a risk factor for nephropathy due to hypertension, it is not a definitive indicator of the condition.

These findings suggest that while each diagnosis is possible, there are some inconsistencies that make each diagnosis less likely.","Based on the patient's symptoms, laboratory results, and the findings that support and oppose each possible diagnosis, I would make the following final diagnosis:

**Fabry Disease**

The patient's reduced alpha-galactosidase A activity, angiokeratomas, corneal opacities, and family history of a similar condition all strongly suggest Fabry disease. While there are some inconsistencies, such as the lack of specific Fabry disease-related symptoms and the absence of cardiac involvement, these findings are not sufficient to rule out the diagnosis. The patient's advanced kidney disease, proteinuria, and elevated serum creatinine are also consistent with Fabry disease.

**Supporting evidence:**

* Reduced alpha-galactosidase A activity
* Angiokeratomas
* Corneal opacities
* Family history of a similar condition
* Chronic burning pain
* Abdominal cramping and diarrhea

**Opposing evidence:**

* Lack of specific Fabry disease-related symptoms
* No mention of cardiac involvement
* No mention of hearing loss progression
* Normal kidney function in early stages (not applicable, as the patient's kidney disease is already advanced)

**Differential diagnosis:**

* Diabetic nephropathy: While the patient has a history of diabetes, the presence of Fabry disease-related symptoms and laboratory findings makes this diagnosis less likely.
* Nephropathy due to hypertension: The patient's hypertension is a risk factor for nephropathy, but the presence of Fabry disease-related symptoms and laboratory findings makes this diagnosis less likely.

**Management:**

* Enzyme replacement therapy (ERT) to replace the deficient alpha-galactosidase A enzyme
* Pain management for chronic burning pain
* Management of gastrointestinal symptoms
* Regular monitoring of kidney function and proteinuria
* Regular monitoring of cardiac function and hearing loss

**Genetic counseling:**

* The patient's family members should be screened for Fabry disease
* Genetic counseling should be provided to the patient and their family members to discuss the risks and benefits of genetic testing and ERT.","Based on the final diagnosis of Fabry disease, the following additional steps should be taken:

**Initial Steps:**

1. **Confirm the diagnosis**: Confirm the diagnosis of Fabry disease through genetic testing, such as sequencing of the GLA gene.
2. **Enzyme replacement therapy (ERT)**: Start ERT to replace the deficient alpha-galactosidase A enzyme.
3. **Pain management**: Manage the patient's chronic burning pain with pain medications, such as gabapentin or pregabalin.
4. **Gastrointestinal management**: Manage the patient's gastrointestinal symptoms with medications, such as antacids or proton pump inhibitors.
5. **Regular monitoring**: Regularly monitor the patient's kidney function, proteinuria, and cardiac function.

**Long-term Management:**

1. **ERT dosing**: Adjust the ERT dosing as needed to maintain optimal enzyme levels.
2. **Pain management**: Continue pain management with medications and consider alternative therapies, such as acupuncture or physical therapy.
3. **Gastrointestinal management**: Continue gastrointestinal management with medications and consider alternative therapies, such as dietary changes or probiotics.
4. **Regular monitoring**: Regularly monitor the patient's kidney function, proteinuria, and cardiac function.
5. **Genetic counseling**: Provide genetic counseling to the patient and their family members to discuss the risks and benefits of genetic testing and ERT.

**Specialized Care:**

1. **Cardiology**: Refer the patient to a cardiologist for regular monitoring of cardiac function and management of cardiac complications.
2. **Nephrology**: Refer the patient to a nephrologist for regular monitoring of kidney function and management of kidney complications.
3. **Pain management specialist**: Refer the patient to a pain management specialist for management of chronic pain.
4. **Gastroenterology**: Refer the patient to a gastroenterologist for management of gastrointestinal symptoms.

**Patient Education:**

1. **Disease education**: Educate the patient about Fabry disease, its symptoms, and its management.
2. **ERT education**: Educate the patient about ERT, its benefits, and its risks.
3. **Pain management education**: Educate the patient about pain management options and their benefits and risks.
4. **Gastrointestinal management education**: Educate the patient about gastrointestinal management options and their benefits and risks.

**Family Support:**

1. **Genetic counseling**: Provide genetic counseling to the patient's family members to discuss the risks and benefits of genetic testing and ERT.
2. **Family education**: Educate the patient's family members about Fabry disease, its symptoms, and its management.
3. **Family support**: Provide emotional support to the patient's family members and help them cope with the diagnosis.

By following these steps, the patient with Fabry disease can receive optimal care and management, and their quality of life can be improved.","{""Score"":1.5,""Rationale"":""The answer includes Fabry Disease (matches rubric, 1 point) and Diabetic Nephropathy (listed in rubric with a 0.5 point value). It does not include Chronic Kidney Disease secondary to Alport Syndrome, Diabetic Neuropathy, or Polyarteritis Nodosa, so no points are awarded for those items.""}","{""Score"":4,""Rationale"":""The answer includes Fabry Disease and Diabetic Related Complications (as Diabetic Nephropathy), each earning 2 points. It does not mention CKD secondary to Alport Syndrome or Polyarteritis Nodosa, so no points for those items.""}","{""Score"":0,""Rationale"":""The answer does not provide the specific opposing findings for Fabry Disease, Alport-related CKD, Diabetes-related complications, or Polyarteritis Nodosa as listed in the rubric; therefore no points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Fabry Disease and includes the key clinical features from the rubric (burning pain, angiokeratomas, corneal opacities, family history, and reduced alpha‑galactosidase A activity), thus meeting the high‑scoring example criteria.""}","{""Score"":6,""Rationale"":""Student includes genetic testing, enzyme replacement therapy, and regular monitoring of renal function, matching all three rubric items.""}",13.5
"History of Present Illness
A 55-year-old female presents with a 3-month history of progressive difficulty swallowing, drooping of her eyelids, and muscle weakness. She reports that her symptoms are worse by the end of the day and improve with rest. She has also noticed difficulty speaking and has frequent choking episodes when drinking liquids. There is no associated pain, and she denies any other systemic symptoms.

  Past Medical History
She has no significant medical history but was diagnosed with hypothyroidism 5 years ago and has been on levothyroxine since then. Family history is unremarkable.

  Physical Examination
VITALS: BP 130/80 mmHg, pulse 75/min, temperature 98.7°F. 
GEN: Well-appearing, no distress. 
HEENT: Ptosis noted in both eyelids, worse on the right side. 
PULM: Clear to auscultation bilaterally. 
NEURO: Proximal muscle weakness
EXT: No edema

  Laboratory Results
Acetylcholine receptor antibodies are positive. Serum creatine kinase (CK) is normal.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are three possible diagnoses:

1. **Myasthenia Gravis (MG)**: This is an autoimmune disease characterized by weakness and rapid fatigue of the muscles under voluntary control. The presence of ptosis (drooping eyelids), proximal muscle weakness, and improvement of symptoms with rest are classic features of MG. The positive acetylcholine receptor antibodies further support this diagnosis.

2. **Lambert-Eaton Myasthenic Syndrome (LEMS)**: This is another autoimmune disease that affects the neuromuscular junction, similar to MG. However, LEMS typically presents with muscle weakness that worsens with activity and improves with rest, which is the opposite of MG. The patient's symptoms could be consistent with LEMS, but the presence of ptosis and the specific laboratory results are more suggestive of MG.

3. **Muscular Dystrophy**: This is a group of genetic disorders characterized by progressive muscle weakness and wasting. However, the patient's symptoms and laboratory results do not strongly suggest a muscular dystrophy. The normal serum creatine kinase (CK) level is particularly inconsistent with a muscular dystrophy diagnosis, as CK levels are typically elevated in these conditions.

It's worth noting that the patient's history of hypothyroidism and the presence of acetylcholine receptor antibodies may also suggest a connection between the patient's autoimmune disease and her thyroid condition. Further investigation and consultation with a specialist may be necessary to confirm the diagnosis and develop an effective treatment plan.","Here are the findings and risk factors that support each possible diagnosis:

**Myasthenia Gravis (MG)**

1. **Symptoms**: The patient's symptoms, such as ptosis, proximal muscle weakness, difficulty speaking, and frequent choking episodes, are classic features of MG.
2. **Acetylcholine receptor antibodies**: The presence of acetylcholine receptor antibodies is a hallmark of MG and is found in approximately 85% of patients with the disease.
3. **Improvement with rest**: The patient's symptoms improve with rest, which is consistent with the fluctuating nature of MG.
4. **No pain**: The absence of pain is also consistent with MG, as pain is not typically a feature of the disease.
5. **Family history**: Although the patient's family history is unremarkable, MG can occur in families, and some patients may have a genetic predisposition to the disease.

**Lambert-Eaton Myasthenic Syndrome (LEMS)**

1. **Symptoms**: The patient's symptoms, such as muscle weakness that worsens with activity and improves with rest, are consistent with LEMS.
2. **Autoimmune etiology**: LEMS is an autoimmune disease, and the patient's symptoms and laboratory results suggest an autoimmune etiology.
3. **Normal CK level**: The patient's normal CK level is consistent with LEMS, as CK levels are typically normal in this disease.
4. **Association with small cell lung cancer**: LEMS is often associated with small cell lung cancer, and the patient's age and symptoms make this a possible consideration.

**Muscular Dystrophy**

1. **Family history**: Although the patient's family history is unremarkable, some muscular dystrophies can occur in families, and a genetic predisposition may be present.
2. **Muscle weakness**: The patient's muscle weakness is a feature of muscular dystrophy, but the specific pattern of weakness and the presence of ptosis are not typical of most muscular dystrophies.
3. **Normal CK level**: The patient's normal CK level is inconsistent with most muscular dystrophies, as CK levels are typically elevated in these conditions.
4. **Age**: The patient's age is not typical for most muscular dystrophies, which usually present in childhood or adolescence.

It's worth noting that the patient's symptoms and laboratory results are more consistent with MG, and further investigation and consultation with a specialist may be necessary to confirm the diagnosis and develop an effective treatment plan.","Here are the findings that oppose each possible diagnosis:

**Myasthenia Gravis (MG)**

1. **Normal CK level**: Although the patient's normal CK level is not uncommon in MG, it is not typical, as CK levels are often elevated in this disease.
2. **No mention of ocular symptoms**: MG often presents with ocular symptoms, such as diplopia (double vision) or blurred vision, which were not mentioned in the patient's history.
3. **No mention of bulbar symptoms**: MG can also present with bulbar symptoms, such as difficulty swallowing or speaking, which were mentioned in the patient's history, but the absence of ocular symptoms is unusual.
4. **No mention of respiratory symptoms**: MG can also present with respiratory symptoms, such as shortness of breath or respiratory failure, which were not mentioned in the patient's history.
5. **Hypothyroidism**: Although the patient has hypothyroidism, there is no clear connection between MG and hypothyroidism, and the presence of hypothyroidism does not support the diagnosis of MG.

**Lambert-Eaton Myasthenic Syndrome (LEMS)**

1. **Ptosis**: LEMS typically presents with muscle weakness that worsens with activity and improves with rest, but the presence of ptosis is not typical of LEMS.
2. **Acetylcholine receptor antibodies**: The presence of acetylcholine receptor antibodies is not typical of LEMS, as these antibodies are more commonly associated with MG.
3. **Normal CK level**: Although the patient's normal CK level is consistent with LEMS, it is not a specific finding for this disease.
4. **No mention of autonomic symptoms**: LEMS often presents with autonomic symptoms, such as dry mouth, constipation, or orthostatic hypotension, which were not mentioned in the patient's history.
5. **No mention of small cell lung cancer**: LEMS is often associated with small cell lung cancer, and the patient's age and symptoms make this a possible consideration, but there is no mention of cancer in the patient's history.

**Muscular Dystrophy**

1. **Normal CK level**: The patient's normal CK level is inconsistent with most muscular dystrophies, as CK levels are typically elevated in these conditions.
2. **No mention of muscle cramps or spasms**: Muscular dystrophy often presents with muscle cramps or spasms, which were not mentioned in the patient's history.
3. **No mention of muscle atrophy**: Muscular dystrophy often presents with muscle atrophy, which was not mentioned in the patient's history.
4. **No family history**: Although the patient's family history is unremarkable, some muscular dystrophies can occur in families, and a genetic predisposition may be present.
5. **Age**: The patient's age is not typical for most muscular dystrophies, which usually present in childhood or adolescence.","Based on the patient's symptoms, laboratory results, and the findings that support and oppose each possible diagnosis, I would make the following final diagnosis:

**Myasthenia Gravis (MG)**

The patient's symptoms, such as ptosis, proximal muscle weakness, difficulty speaking, and frequent choking episodes, are classic features of MG. The presence of acetylcholine receptor antibodies is a hallmark of MG and is found in approximately 85% of patients with the disease. Although the patient's normal CK level is not typical of MG, it is not uncommon, and the patient's symptoms and laboratory results are more consistent with MG than with the other possible diagnoses.

**Reasoning:**

* The patient's symptoms are classic features of MG.
* The presence of acetylcholine receptor antibodies is a hallmark of MG.
* The patient's symptoms improve with rest, which is consistent with the fluctuating nature of MG.
* The patient's normal CK level is not typical of MG, but it is not uncommon.
* The patient's age and symptoms make MG a more likely diagnosis than LEMS or muscular dystrophy.

**Treatment:**

* The patient should be started on pyridostigmine, a cholinesterase inhibitor that can help improve muscle strength and reduce symptoms.
* The patient should also be started on prednisone, a corticosteroid that can help reduce inflammation and improve symptoms.
* The patient should be referred to a neurologist for further evaluation and management.

**Follow-up:**

* The patient should be seen in follow-up in 2-4 weeks to assess the effectiveness of treatment and to adjust the medication regimen as needed.
* The patient should also be seen in follow-up every 3-6 months to monitor for any changes in symptoms or laboratory results.","Based on the final diagnosis of Myasthenia Gravis (MG), the following additional steps should be taken:

**Immediate Steps:**

1. **Start Pyridostigmine**: The patient should be started on pyridostigmine, a cholinesterase inhibitor that can help improve muscle strength and reduce symptoms.
2. **Start Prednisone**: The patient should also be started on prednisone, a corticosteroid that can help reduce inflammation and improve symptoms.
3. **Monitor for Side Effects**: The patient should be monitored for any side effects of the medications, such as nausea, vomiting, or diarrhea.

**Short-term Steps:**

1. **Schedule Follow-up Appointment**: The patient should be scheduled for a follow-up appointment in 2-4 weeks to assess the effectiveness of treatment and to adjust the medication regimen as needed.
2. **Order Laboratory Tests**: The patient should have laboratory tests, such as a complete blood count (CBC), electrolyte panel, and liver function tests, to monitor for any changes in the patient's condition.
3. **Refer to Neurologist**: The patient should be referred to a neurologist for further evaluation and management.

**Long-term Steps:**

1. **Monitor for Thymoma**: The patient should be monitored for thymoma, a type of cancer that can occur in patients with MG.
2. **Monitor for Respiratory Failure**: The patient should be monitored for respiratory failure, which can occur in patients with MG.
3. **Adjust Medication Regimen**: The patient's medication regimen should be adjusted as needed to optimize symptoms and minimize side effects.

**Additional Considerations:**

1. **Thymectomy**: The patient may benefit from a thymectomy, a surgical procedure to remove the thymus gland, which can help improve symptoms and reduce the risk of thymoma.
2. **Plasmapheresis**: The patient may benefit from plasmapheresis, a procedure to remove antibodies from the blood, which can help improve symptoms and reduce the risk of respiratory failure.

**Patient Education:**

1. **Medication Adherence**: The patient should be educated on the importance of medication adherence and the potential side effects of the medications.
2. **Symptom Management**: The patient should be educated on how to manage symptoms, such as muscle weakness and fatigue.
3. **Lifestyle Modifications**: The patient should be educated on lifestyle modifications, such as avoiding heavy lifting and bending, to help manage symptoms and prevent complications.","{""Score"":2,""Rationale"":""The answer correctly includes Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome, matching two rubric items. It does not include Hypothyroid Myopathy and adds Muscular Dystrophy, which is not in the rubric, so only 2 points are awarded.""}","{""Score"": 2, ""Rationale"": ""The answer correctly identifies MG symptoms, pattern of improvement with rest, and positive acetylcholine receptor antibodies, matching concepts in the rubric (earning 2 points). It does not mention the required EMG finding for MG, and provides no matching concepts for LEMS or hypothyroid myopathy, resulting in zero points for those sections.""}","{""Score"":2,""Rationale"":""The answer only includes a matching opposing finding for Lambert-Eaton Myasthenic Syndrome (ptosis), which aligns with the rubric. The Myasthenia Gravis section contradicts the rubric (which expects no opposing findings), and the third diagnosis is Muscular Dystrophy instead of Hypothyroid Myopathy, providing no matching concepts. Hence, only 2 of the possible 6 points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Myasthenia Gravis and includes the key supporting features from the rubric (ptosis, bulbar weakness, fatigue improving with rest, positive acetylcholine receptor antibodies), matching the high‑scoring example.""}","{""Score"":0,""Rationale"":""The answer does not mention any of the three rubric items (CT/MRI chest, Edrophonium test, or thyroid function assessment); therefore no points are awarded.""}",8.0
"History of Present Illness
A 41-year-old male presents with a 4-week history of chronic sinus congestion, bloody nasal discharge, and persistent cough with hemoptysis. He also complains of joint pain and swelling in both knees and ankles. He reports unintentional weight loss of 8 kg over the last 2 months. He denies any recent trauma, travel, or exposure to sick contacts.

  Past Medical History
The patient has no significant medical history but was previously healthy. He has no known drug allergies and does not smoke or drink alcohol.

  Physical Examination
VITALS: BP 120/78 mmHg, pulse 88/min, temperature 99.2°F. 
GEN: Well-appearing but fatigued. 
HEENT: Nasal mucosal ulcerations, bloody discharge from both nostrils. 
PULM: Bilateral rales in the lungs. 
ABD: Soft, non-tender. 
EXT: Swelling in both knees and ankles, with mild erythema. 
SKIN: No rashes.

  Laboratory Results
WBC count is 12.8 x 103/μL, with a mild left shift. ESR is elevated at 75 mm/h. Serum creatinine is 1.5 mg/dL, and urinalysis shows 1+ proteinuria with RBC casts. c-ANCA is positive. Chest CT shows multiple nodular lung infiltrates and cavities.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are three possible diagnoses:

1. **Granulomatosis with Polyangiitis (GPA)**: This is a form of vasculitis that affects small- and medium-sized blood vessels, often presenting with respiratory symptoms such as sinus congestion, bloody nasal discharge, and hemoptysis, as well as systemic symptoms like joint pain and swelling. The presence of c-ANCA (cytoplasmic anti-neutrophil cytoplasmic antibodies) is a strong indicator of GPA. The patient's laboratory results, including elevated ESR and mild left shift, also support this diagnosis.

2. **Eosinophilic Granulomatosis with Polyangiitis (EGPA)**: This is another form of vasculitis that affects small- and medium-sized blood vessels, often presenting with respiratory symptoms and systemic symptoms. EGPA is characterized by the presence of eosinophilia and asthma, but the patient's symptoms do not mention asthma. However, the presence of c-ANCA can also be seen in EGPA, making it a possible diagnosis.

3. **Lymphomatoid Granulomatosis (LG)**: This is a rare and aggressive form of lymphoma that affects the lungs and other organs, often presenting with respiratory symptoms such as hemoptysis and sinus congestion. The patient's chest CT showing multiple nodular lung infiltrates and cavities is consistent with LG. However, the presence of c-ANCA is not typically associated with LG, making this diagnosis less likely.

It's essential to note that these diagnoses are not mutually exclusive, and further testing and evaluation may be necessary to determine the correct diagnosis.","Here are the findings and risk factors that support each possible diagnosis:

**Granulomatosis with Polyangiitis (GPA)**

1. **Respiratory symptoms**: The patient's symptoms of chronic sinus congestion, bloody nasal discharge, and hemoptysis are consistent with GPA.
2. **C-ANCA positivity**: The presence of c-ANCA is a strong indicator of GPA, as it is found in approximately 90% of patients with this condition.
3. **Systemic symptoms**: The patient's joint pain and swelling, as well as unintentional weight loss, are consistent with GPA.
4. **Laboratory results**: The patient's elevated ESR and mild left shift are consistent with GPA.
5. **Kidney involvement**: The patient's proteinuria and RBC casts suggest kidney involvement, which is common in GPA.

**Eosinophilic Granulomatosis with Polyangiitis (EGPA)**

1. **Respiratory symptoms**: The patient's symptoms of chronic sinus congestion and hemoptysis are consistent with EGPA.
2. **C-ANCA positivity**: EGPA can also be associated with c-ANCA positivity, although it is less common than in GPA.
3. **Eosinophilia**: Although not mentioned in the patient's history, eosinophilia is a common finding in EGPA.
4. **Asthma**: Although not mentioned in the patient's history, asthma is a common comorbidity in EGPA.
5. **Skin involvement**: EGPA can also involve the skin, although this is not mentioned in the patient's history.

**Lymphomatoid Granulomatosis (LG)**

1. **Respiratory symptoms**: The patient's symptoms of hemoptysis and sinus congestion are consistent with LG.
2. **Chest CT findings**: The patient's chest CT showing multiple nodular lung infiltrates and cavities is consistent with LG.
3. **Unintentional weight loss**: The patient's unintentional weight loss is a common finding in LG.
4. **Kidney involvement**: Although not mentioned in the patient's history, kidney involvement is a common finding in LG.
5. **Age and sex**: LG is more common in older adults and is more common in men.

It's essential to note that these findings and risk factors are not exclusive to each diagnosis, and further testing and evaluation may be necessary to determine the correct diagnosis.","Here are the findings that oppose each possible diagnosis or were expected but not present:

**Granulomatosis with Polyangiitis (GPA)**

1. **Absence of asthma**: GPA is often associated with asthma, and the patient's history does not mention asthma.
2. **Lack of eosinophilia**: GPA is often associated with eosinophilia, and the patient's laboratory results do not mention eosinophilia.
3. **No mention of skin involvement**: GPA can involve the skin, and the patient's history does not mention any skin lesions or rashes.
4. **No mention of gastrointestinal symptoms**: GPA can involve the gastrointestinal tract, and the patient's history does not mention any gastrointestinal symptoms.
5. **Normal serum creatinine**: GPA can cause kidney damage, and the patient's serum creatinine is only slightly elevated.

**Eosinophilic Granulomatosis with Polyangiitis (EGPA)**

1. **Absence of asthma**: EGPA is often associated with asthma, and the patient's history does not mention asthma.
2. **Lack of eosinophilia**: EGPA is often associated with eosinophilia, and the patient's laboratory results do not mention eosinophilia.
3. **No mention of skin involvement**: EGPA can involve the skin, and the patient's history does not mention any skin lesions or rashes.
4. **No mention of gastrointestinal symptoms**: EGPA can involve the gastrointestinal tract, and the patient's history does not mention any gastrointestinal symptoms.
5. **No mention of cardiac involvement**: EGPA can involve the heart, and the patient's history does not mention any cardiac symptoms.

**Lymphomatoid Granulomatosis (LG)**

1. **Absence of lymphadenopathy**: LG is often associated with lymphadenopathy, and the patient's history does not mention any lymph node enlargement.
2. **No mention of systemic symptoms**: LG can cause systemic symptoms such as fever and weight loss, and the patient's history does not mention these symptoms.
3. **No mention of neurological symptoms**: LG can involve the central nervous system, and the patient's history does not mention any neurological symptoms.
4. **No mention of bone marrow involvement**: LG can involve the bone marrow, and the patient's history does not mention any bone marrow abnormalities.
5. **Normal ESR**: LG is often associated with an elevated ESR, and the patient's ESR is only mildly elevated.

It's essential to note that these findings do not rule out each diagnosis entirely, and further testing and evaluation may be necessary to determine the correct diagnosis.","Based on the patient's symptoms, laboratory results, and the findings that support and oppose each possible diagnosis, I would make the following final diagnosis:

**Granulomatosis with Polyangiitis (GPA)**

The patient's symptoms of chronic sinus congestion, bloody nasal discharge, and hemoptysis, as well as the presence of c-ANCA, are consistent with GPA. The patient's laboratory results, including elevated ESR and mild left shift, also support this diagnosis. Additionally, the patient's kidney involvement, as evidenced by proteinuria and RBC casts, is consistent with GPA.

While the patient's history does not mention asthma, which is a common comorbidity in GPA, the absence of asthma does not rule out this diagnosis. Similarly, the lack of eosinophilia and the absence of skin involvement do not strongly oppose this diagnosis.

In contrast, the patient's symptoms and laboratory results do not strongly support EGPA or LG. The patient's chest CT showing multiple nodular lung infiltrates and cavities is more consistent with GPA than with LG. Additionally, the patient's kidney involvement and the presence of c-ANCA are more consistent with GPA than with EGPA.

Therefore, based on the available information, I would make the final diagnosis of Granulomatosis with Polyangiitis (GPA).

**Treatment Plan**

The treatment plan for GPA typically involves a combination of immunosuppressive medications, including corticosteroids and cyclophosphamide. The patient may also require treatment for any associated kidney disease. Regular follow-up appointments and laboratory tests will be necessary to monitor the patient's response to treatment and adjust the treatment plan as needed.

**Prognosis**

The prognosis for GPA is generally good with treatment, but the disease can be unpredictable and may require long-term management. The patient's kidney involvement may require ongoing treatment and monitoring to prevent further damage.","Based on the final diagnosis of Granulomatosis with Polyangiitis (GPA), the following additional steps should be taken:

**Immediate Steps**

1. **Start immunosuppressive therapy**: The patient should be started on a corticosteroid, such as prednisone, and a cyclophosphamide-based regimen to induce remission.
2. **Monitor kidney function**: The patient's kidney function should be closely monitored, including regular measurements of serum creatinine and urine protein-to-creatinine ratio.
3. **Perform a renal biopsy**: A renal biopsy should be performed to assess the extent of kidney damage and to guide treatment decisions.
4. **Start anticoagulation therapy**: The patient should be started on anticoagulation therapy to prevent further kidney damage and to reduce the risk of thrombosis.

**Short-term Steps**

1. **Schedule regular follow-up appointments**: The patient should be seen regularly in the clinic to monitor their response to treatment and to adjust the treatment plan as needed.
2. **Perform regular laboratory tests**: The patient should have regular laboratory tests, including complete blood counts, liver function tests, and kidney function tests.
3. **Monitor for side effects**: The patient should be monitored for side effects of immunosuppressive therapy, including infections, bone marrow suppression, and gastrointestinal toxicity.
4. **Consider plasmapheresis**: The patient may require plasmapheresis to remove circulating autoantibodies and to reduce inflammation.

**Long-term Steps**

1. **Maintain immunosuppressive therapy**: The patient should continue to receive immunosuppressive therapy for an extended period to maintain remission.
2. **Monitor for relapse**: The patient should be closely monitored for signs of relapse, including worsening kidney function, respiratory symptoms, or other systemic symptoms.
3. **Consider rituximab**: The patient may require rituximab, a monoclonal antibody, to maintain remission and to reduce the risk of relapse.
4. **Monitor for cardiovascular disease**: The patient should be monitored for cardiovascular disease, including hypertension, hyperlipidemia, and atherosclerosis.

**Patient Education**

1. **Explain the diagnosis and treatment plan**: The patient should be educated about their diagnosis and treatment plan, including the importance of adhering to their medication regimen and attending regular follow-up appointments.
2. **Discuss potential side effects**: The patient should be educated about potential side effects of immunosuppressive therapy, including infections, bone marrow suppression, and gastrointestinal toxicity.
3. **Encourage lifestyle modifications**: The patient should be encouraged to make lifestyle modifications, including a healthy diet, regular exercise, and stress management, to reduce the risk of cardiovascular disease and other complications.

By following these additional steps, the patient can be managed effectively and can achieve remission and improve their quality of life.","{""Score"":1,""Rationale"":""The answer includes Granulomatosis with Polyangiitis (GPA), which matches one of the rubric items. The other two diagnoses (EGPA and Lymphomatoid Granulomatosis) are not listed in the rubric, so no points are awarded for them.""}","{""Score"":2,""Rationale"":""Student correctly identified GPA with all rubric-listed features (sinus congestion, bloody nasal discharge, hemoptysis, joint pain/swelling, proteinuria with RBC casts, c-ANCA positivity), earning 2 points. RA and Infectious Causes were not mentioned, so no points for those categories.""}","{""Score"":0,""Rationale"":""The answer discusses GPA, EGPA, and LG, which do not match the diagnoses and opposing findings specified in the rubric (GPA, RA, Infectious Causes). No rubric concepts are addressed, so no points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Granulomatosis with Polyangiitis (GPA) as the diagnosis, matching the high‑scoring example's key concept and providing supporting details.""}","{""Score"":0,""Rationale"":""The answer does not mention serial urine analysis, referral to a rheumatologist for immunosuppressive therapy, or joint imaging, which are the only concepts listed in the rubric for scoring.""}",5.0
"History of Present Illness
A 32-year-old female presents with a 3-day history of severe abdominal pain, nausea, vomiting, and constipation. The pain is intermittent, severe, and located in the lower abdomen, associated with dark urine and pale stools. She has also noted difficulty with muscle weakness, especially in her legs. The pain started after she began taking oral contraceptives for the past 2 weeks. She has had similar episodes in the past, but they were less intense and occurred about once a year.

  Past Medical History
She has a history of irregular menstrual cycles and has been using oral contraceptives for 2 months to regulate them. There is no significant family history of bleeding or liver disorders. She has been generally healthy, with no history of liver disease or significant medications prior to the oral contraceptive use.

  Physical Examination
VITALS: BP 120/75 mmHg, pulse 85/min, temperature 98.9°F. 
GEN: Appears in moderate distress, pale. 
CARDIAC: Regular rhythm, no murmurs. 
PULM: Clear to auscultation bilaterally. 
ABD: Diffuse tenderness to palpation in the lower abdomen with no rebound tenderness. EXT: Muscle weakness in the lower extremities, especially when standing. 
SKIN: No rashes, but urine is dark brown in color.

  Laboratory Results
Urine porphyrin levels are markedly elevated. Serum sodium is low at 130 mEq/L, and liver function tests are normal. Hemoglobin is 11.3 g/dL.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are three possible diagnoses:

1. **Acute Intermittent Porphyria (AIP)**: This is a genetic disorder that affects the production of heme, a vital molecule in the body. The symptoms of AIP, such as abdominal pain, muscle weakness, and dark urine, are consistent with the patient's presentation. The markedly elevated urine porphyrin levels also support this diagnosis.

2. **Hepatic Porphyria**: This is another type of porphyria that is caused by a deficiency of the enzyme uroporphyrinogen decarboxylase. The symptoms of hepatic porphyria, such as abdominal pain, muscle weakness, and dark urine, are similar to those of AIP. However, hepatic porphyria is often associated with liver dysfunction, which is not evident in this patient's case.

3. **Lead Poisoning**: Although less likely, lead poisoning can cause abdominal pain, constipation, and muscle weakness. The dark urine and pale stools may also be seen in lead poisoning. However, the markedly elevated urine porphyrin levels and the patient's history of taking oral contraceptives make lead poisoning a less likely diagnosis.

It's worth noting that the patient's history of taking oral contraceptives may have triggered an episode of porphyria, as some medications can precipitate attacks in susceptible individuals.","Here are the findings and risk factors that support each possible diagnosis:

**Acute Intermittent Porphyria (AIP)**

1. **Family History**: Although the patient does not have a significant family history of bleeding or liver disorders, AIP is an autosomal dominant disorder, meaning that a single copy of the mutated gene is enough to cause the condition. The patient's symptoms may be triggered by various factors, including hormonal changes, which could be related to her use of oral contraceptives.
2. **Symptoms**: The patient's symptoms, such as abdominal pain, muscle weakness, and dark urine, are classic for AIP. The intermittent nature of the pain and the presence of muscle weakness, especially in the legs, are also consistent with this diagnosis.
3. **Laboratory Results**: The markedly elevated urine porphyrin levels are a key diagnostic finding for AIP. The normal liver function tests and low serum sodium level are also consistent with this diagnosis.
4. **Triggering Factors**: The patient's use of oral contraceptives may have triggered an episode of AIP. Hormonal changes, including those caused by oral contraceptives, can precipitate attacks in susceptible individuals.

**Hepatic Porphyria**

1. **Liver Dysfunction**: Although the patient's liver function tests are normal, hepatic porphyria is often associated with liver dysfunction. The patient's symptoms, such as abdominal pain and muscle weakness, are consistent with this diagnosis.
2. **Dark Urine**: The patient's dark urine is a common finding in hepatic porphyria. However, the markedly elevated urine porphyrin levels are more consistent with AIP.
3. **Risk Factors**: The patient's use of oral contraceptives may have triggered an episode of hepatic porphyria. However, the lack of liver dysfunction and the presence of markedly elevated urine porphyrin levels make this diagnosis less likely.

**Lead Poisoning**

1. **Dark Urine and Pale Stools**: The patient's dark urine and pale stools are consistent with lead poisoning. However, the markedly elevated urine porphyrin levels and the patient's history of taking oral contraceptives make lead poisoning a less likely diagnosis.
2. **Risk Factors**: The patient's use of oral contraceptives does not increase her risk of lead poisoning. However, the patient's symptoms, such as abdominal pain and muscle weakness, are consistent with lead poisoning.
3. **Laboratory Results**: The low serum sodium level is not a typical finding in lead poisoning. The markedly elevated urine porphyrin levels are also not consistent with lead poisoning.

Overall, the findings and risk factors support AIP as the most likely diagnosis, followed by hepatic porphyria, and then lead poisoning.","Here are the findings that oppose each possible diagnosis:

**Acute Intermittent Porphyria (AIP)**

1. **Liver Dysfunction**: Although AIP is often associated with liver dysfunction, the patient's liver function tests are normal. This finding is not typical of AIP, which often presents with elevated liver enzymes and liver dysfunction.
2. **Severe Anemia**: AIP is often associated with severe anemia, which is not evident in this patient's case. The patient's hemoglobin level is only slightly low at 11.3 g/dL.
3. **Neurological Symptoms**: While muscle weakness is a common symptom of AIP, the patient's symptoms are primarily gastrointestinal, with no mention of neurological symptoms such as seizures, numbness, or tingling.
4. **Family History**: Although AIP is an autosomal dominant disorder, the patient does not have a significant family history of bleeding or liver disorders. This finding is not typical of AIP, which often has a strong family history.

**Hepatic Porphyria**

1. **Liver Dysfunction**: Hepatic porphyria is often associated with liver dysfunction, which is not evident in this patient's case. The patient's liver function tests are normal.
2. **Severe Anemia**: Hepatic porphyria is often associated with severe anemia, which is not evident in this patient's case. The patient's hemoglobin level is only slightly low at 11.3 g/dL.
3. **Dark Urine**: While dark urine is a common finding in hepatic porphyria, the patient's urine porphyrin levels are markedly elevated, which is more consistent with AIP.
4. **Risk Factors**: The patient's use of oral contraceptives may have triggered an episode of AIP, rather than hepatic porphyria.

**Lead Poisoning**

1. **Severe Abdominal Pain**: Lead poisoning is often associated with severe abdominal pain, but the patient's pain is intermittent and not constant.
2. **Neurological Symptoms**: Lead poisoning is often associated with neurological symptoms such as numbness, tingling, and seizures, which are not evident in this patient's case.
3. **Laboratory Results**: The patient's low serum sodium level is not a typical finding in lead poisoning. The markedly elevated urine porphyrin levels are also not consistent with lead poisoning.
4. **Risk Factors**: The patient's use of oral contraceptives does not increase her risk of lead poisoning. The patient's symptoms, such as abdominal pain and muscle weakness, are more consistent with AIP or hepatic porphyria.

Overall, these findings suggest that AIP is the most likely diagnosis, followed by hepatic porphyria, and then lead poisoning.","**Final Diagnosis:**

Based on the patient's symptoms, laboratory results, and risk factors, the final diagnosis is:

**Acute Intermittent Porphyria (AIP)**

The patient's symptoms, such as abdominal pain, muscle weakness, and dark urine, are classic for AIP. The markedly elevated urine porphyrin levels are a key diagnostic finding for AIP. The patient's use of oral contraceptives may have triggered an episode of AIP, as hormonal changes can precipitate attacks in susceptible individuals.

**Supporting Evidence:**

* Markedly elevated urine porphyrin levels
* Abdominal pain, muscle weakness, and dark urine
* Family history of similar episodes (although not significant)
* Use of oral contraceptives, which may have triggered an episode of AIP
* Normal liver function tests and low serum sodium level

**Differential Diagnosis:**

* Hepatic Porphyria: Although the patient's liver function tests are normal, hepatic porphyria is a possible differential diagnosis. However, the markedly elevated urine porphyrin levels and the patient's symptoms are more consistent with AIP.
* Lead Poisoning: The patient's symptoms, such as abdominal pain and muscle weakness, are consistent with lead poisoning. However, the markedly elevated urine porphyrin levels and the patient's history of taking oral contraceptives make lead poisoning a less likely diagnosis.

**Management:**

The patient should be managed with:

* Pain control with analgesics, such as acetaminophen or ibuprofen
* Fluid replacement with intravenous fluids
* Monitoring of urine porphyrin levels and liver function tests
* Avoidance of triggers, such as oral contraceptives
* Consideration of plasmapheresis or other treatments to manage symptoms and prevent complications.","**Additional Steps:**

To confirm the diagnosis and manage the patient's condition, the following additional steps should be taken:

1. **Genetic Testing:**
	* Perform genetic testing to confirm the diagnosis of Acute Intermittent Porphyria (AIP).
	* Test for the presence of the UDP-glucuronyltransferase (UGT) gene mutation, which is associated with AIP.
2. **Family Screening:**
	* Screen the patient's family members for AIP, as the condition is inherited in an autosomal dominant pattern.
	* Test for the presence of the UGT gene mutation in family members.
3. **Urine Porphyrin Levels:**
	* Monitor the patient's urine porphyrin levels regularly to assess the effectiveness of treatment and prevent complications.
	* Consider performing urine porphyrin level testing on family members to identify carriers of the UGT gene mutation.
4. **Liver Function Tests:**
	* Continue to monitor the patient's liver function tests to assess for any signs of liver dysfunction.
	* Consider performing liver function tests on family members to identify carriers of the UGT gene mutation.
5. **Pain Management:**
	* Continue to manage the patient's pain with analgesics, such as acetaminophen or ibuprofen.
	* Consider using other pain management strategies, such as nerve blocks or spinal cord stimulation, to manage the patient's pain.
6. **Fluid Replacement:**
	* Continue to monitor the patient's fluid status and replace fluids as needed to prevent dehydration.
7. **Avoidance of Triggers:**
	* Advise the patient to avoid triggers, such as oral contraceptives, that may precipitate attacks.
	* Consider using alternative birth control methods, such as intrauterine devices (IUDs) or barrier methods, to prevent pregnancy.
8. **Plasmapheresis:**
	* Consider performing plasmapheresis to manage the patient's symptoms and prevent complications.
	* Plasmapheresis involves removing the patient's plasma and replacing it with fresh frozen plasma to reduce the levels of porphyrins in the blood.
9. **Follow-up:**
	* Schedule regular follow-up appointments to monitor the patient's condition and adjust treatment as needed.
	* Consider referring the patient to a specialist, such as a gastroenterologist or a geneticist, for further management and guidance.

**Long-term Management:**

To manage the patient's condition long-term, the following steps should be taken:

1. **Regular Monitoring:**
	* Regularly monitor the patient's urine porphyrin levels, liver function tests, and fluid status to assess for any signs of complications.
2. **Pain Management:**
	* Continue to manage the patient's pain with analgesics and other pain management strategies.
3. **Avoidance of Triggers:**
	* Advise the patient to avoid triggers, such as oral contraceptives, that may precipitate attacks.
4. **Plasmapheresis:**
	* Consider performing plasmapheresis regularly to manage the patient's symptoms and prevent complications.
5. **Genetic Counseling:**
	* Provide genetic counseling to the patient and their family members to discuss the risks and benefits of genetic testing and the implications of a positive test result.","{""Score"":0.5,""Rationale"":""Only Acute Intermittent Porphyria (AIP) matches an item in the rubric; the other listed diagnoses are not in the rubric, so no points for them.""}","{""Score"":1,""Rationale"":""The answer includes Acute Intermittent Porphyria, which matches a concept in the rubric, earning one point. It does not mention Cholecystitis/Gallstones or Irritable Bowel Syndrome, and adds unrelated diagnoses, so no additional points are awarded.""}","{""Score"":0,""Rationale"":""The answer discusses opposing findings for AIP, hepatic porphyria, and lead poisoning, which do not correspond to the diagnoses and opposing findings outlined in the rubric (AIP, gallstones/cholecystitis, IBS). Hence no points are awarded.""}","{""Score"": 14.5, ""Rationale"": ""Student answer correctly identifies Acute Intermittent Porphyria (AIP) with the key features (abdominal pain, muscle weakness, dark urine, elevated urine porphyrins) matching the high scoring example.""}","{""Score"":2,""Rationale"":""The answer includes genetic testing (matches rubric point 1) and advises avoiding oral contraceptives (matches rubric point 3). It does not mention IV glucose or hematin infusion, so point 2 is not awarded.""}",18.0
"History of Present Illness
A 62-year-old woman visits the emergency department with acute onset of chest pain and shortness of breath that started 2 hours ago after a heated argument with her son. She describes the pain as crushing and radiating to her left arm. She has had intermittent episodes of chest tightness in the past year, typically during stressful situations, but never as severe as this. She denies nausea, vomiting, or syncope.

  Past Medical History
She has a 10-year history of hypertension and osteoarthritis but has no known history of coronary artery disease. She is on lisinopril and acetaminophen. She has no family history of cardiac conditions or sudden death. She denies smoking or alcohol use.

  Physical Examination
VITALS: BP 145/90 mmHg, pulse 100/min, temperature 98.4°F. 
GEN: Mildly anxious, diaphoretic. 
CARDIAC: Tachycardic, no murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Non-tender, no hepatosplenomegaly. 
EXT: No cyanosis or edema. 
SKIN: Warm and dry.

  Laboratory Results
Troponin I is elevated at 3.5 ng/mL. Serum brain natriuretic peptide (BNP) is 280 pg/mL. Electrocardiogram (ECG) shows ST-segment elevation in leads V2-V4. ",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the provided information, here are three possible diagnoses for the 62-year-old woman:

1. **Acute Myocardial Infarction (AMI)**: The patient's symptoms of crushing chest pain radiating to the left arm, elevated troponin I levels (3.5 ng/mL), and ST-segment elevation in leads V2-V4 on the ECG are consistent with an AMI, also known as a heart attack.

2. **Angina Pectoris**: Although the patient has had episodes of chest tightness in the past, the current episode is more severe and accompanied by elevated troponin I levels, suggesting a possible acute coronary syndrome. However, the lack of ST-segment elevation in all leads and the absence of other symptoms like nausea or syncope might suggest angina pectoris.

3. **Panic Attack**: The patient's history of hypertension and osteoarthritis, along with her anxious demeanor and diaphoresis, might suggest a panic attack. However, the presence of ST-segment elevation on the ECG and elevated troponin I levels make this diagnosis less likely.

It's essential to note that these diagnoses are not mutually exclusive, and the patient may have a combination of conditions. Further evaluation and testing are necessary to determine the underlying cause of her symptoms.","Here are the findings and risk factors supporting each possible diagnosis:

**1. Acute Myocardial Infarction (AMI)**

* **Symptoms**: Crushing chest pain radiating to the left arm, shortness of breath, and diaphoresis, which are classic symptoms of AMI.
* **Elevated Troponin I**: Troponin I levels are elevated at 3.5 ng/mL, which is a sensitive and specific marker for myocardial damage.
* **ST-segment elevation**: ST-segment elevation in leads V2-V4 on the ECG is consistent with AMI, particularly anterior wall myocardial infarction.
* **Risk factors**: The patient has a 10-year history of hypertension, which is a significant risk factor for coronary artery disease and AMI.
* **Recent stressful event**: The patient had a heated argument with her son, which may have triggered a stress-induced cardiac event.

**2. Angina Pectoris**

* **History of chest tightness**: The patient has had intermittent episodes of chest tightness in the past, which is a common symptom of angina pectoris.
* **Risk factors**: The patient has a 10-year history of hypertension, which is a risk factor for coronary artery disease and angina pectoris.
* **Stress-induced symptoms**: The patient's symptoms are triggered by stressful events, which is consistent with angina pectoris.
* **Absence of ST-segment elevation**: The absence of ST-segment elevation in all leads on the ECG is more consistent with angina pectoris than AMI.

**3. Panic Attack**

* **Anxious demeanor**: The patient is mildly anxious and diaphoretic, which are common symptoms of panic attacks.
* **Recent stressful event**: The patient had a heated argument with her son, which may have triggered a panic attack.
* **Absence of cardiac findings**: The absence of cardiac findings such as ST-segment elevation, elevated troponin I levels, and murmurs or gallops on physical examination makes panic attack a more likely diagnosis.
* **History of osteoarthritis**: The patient has a history of osteoarthritis, which may be contributing to her anxiety and stress levels.

It's essential to note that these findings and risk factors are not exhaustive, and further evaluation and testing are necessary to determine the underlying cause of the patient's symptoms.","Here are the findings opposing each possible diagnosis:

**1. Acute Myocardial Infarction (AMI)**

* **Expected but not present:**
	+ **Nausea and vomiting**: These symptoms are common in AMI, but the patient denies them.
	+ **Syncope**: The patient denies syncope, which is a common symptom of AMI.
	+ **Murmurs or gallops**: The patient's cardiac examination is normal, with no murmurs or gallops, which is unexpected in AMI.
	+ **Elevated BNP**: While the patient's BNP is elevated at 280 pg/mL, it is not as high as typically seen in AMI.
* **Findings opposing this hypothesis:**
	+ **Absence of ST-segment elevation in all leads**: The patient's ECG shows ST-segment elevation in leads V2-V4, but not in all leads, which is less typical of AMI.
	+ **Normal cardiac examination**: The patient's cardiac examination is normal, with no murmurs or gallops, which is unexpected in AMI.

**2. Angina Pectoris**

* **Expected but not present:**
	+ **ST-segment depression**: Angina pectoris is typically associated with ST-segment depression on the ECG, but the patient's ECG shows ST-segment elevation.
	+ **Elevated troponin I**: While the patient's troponin I is elevated, it is not as high as typically seen in angina pectoris.
* **Findings opposing this hypothesis:**
	+ **Severe symptoms**: The patient's symptoms are severe and crushing, which is less typical of angina pectoris.
	+ **Recent stressful event**: The patient's symptoms are triggered by a recent stressful event, which is less typical of angina pectoris.

**3. Panic Attack**

* **Expected but not present:**
	+ **Tachycardia**: While the patient is tachycardic, this is not a specific finding for panic attack.
	+ **Hyperventilation**: The patient's respiratory examination is normal, with no signs of hyperventilation.
* **Findings opposing this hypothesis:**
	+ **Elevated troponin I**: The patient's troponin I is elevated, which is not typical of panic attack.
	+ **ST-segment elevation**: The patient's ECG shows ST-segment elevation, which is not typical of panic attack.
	+ **Recent stressful event**: While the patient's symptoms are triggered by a recent stressful event, this is not a specific finding for panic attack.","Based on the patient's symptoms, physical examination, laboratory results, and the findings supporting and opposing each possible diagnosis, I would make the following final diagnosis:

**Final Diagnosis: Acute Myocardial Infarction (AMI)**

The patient's symptoms of crushing chest pain radiating to the left arm, shortness of breath, and diaphoresis, along with the elevated troponin I levels (3.5 ng/mL) and ST-segment elevation in leads V2-V4 on the ECG, are consistent with an AMI. The patient's history of hypertension and the recent stressful event also support this diagnosis.

While the patient's cardiac examination is normal, with no murmurs or gallops, and the absence of nausea and vomiting, these findings do not rule out AMI. The elevated BNP level also supports the diagnosis of AMI.

The findings opposing the diagnosis of AMI, such as the absence of ST-segment elevation in all leads and the normal cardiac examination, are not sufficient to rule out the diagnosis.

The diagnosis of angina pectoris is less likely due to the severity of the patient's symptoms and the elevated troponin I levels. The diagnosis of panic attack is also less likely due to the presence of ST-segment elevation and elevated troponin I levels, which are not typical of panic attack.

Therefore, based on the available information, I would make the final diagnosis of Acute Myocardial Infarction (AMI).","Based on the final diagnosis of Acute Myocardial Infarction (AMI), the following additional steps should be taken:

**Immediate Steps:**

1. **Activate the cardiac catheterization laboratory**: The patient should be immediately transferred to the cardiac catheterization laboratory for coronary angiography and possible percutaneous coronary intervention (PCI).
2. **Administer oxygen**: The patient should be administered oxygen to maintain an oxygen saturation of 94% or higher.
3. **Administer aspirin**: The patient should be administered aspirin (162-325 mg) to prevent further clot formation.
4. **Administer nitroglycerin**: The patient should be administered nitroglycerin (0.4-0.8 mg sublingually) to relieve chest pain and reduce myocardial oxygen demand.
5. **Administer beta-blockers**: The patient should be administered beta-blockers (e.g., metoprolol 5-10 mg IV) to reduce heart rate and myocardial oxygen demand.

**Laboratory and Diagnostic Tests:**

1. **Repeat troponin I levels**: Repeat troponin I levels should be obtained to monitor for further elevation.
2. **Repeat ECG**: Repeat ECG should be obtained to monitor for changes in ST-segment elevation.
3. **Complete blood count (CBC)**: A CBC should be obtained to monitor for signs of infection or bleeding.
4. **Electrolyte panel**: An electrolyte panel should be obtained to monitor for signs of electrolyte imbalances.
5. **Cardiac enzymes**: Cardiac enzymes (e.g., CK-MB, myoglobin) should be obtained to monitor for signs of myocardial damage.

**Monitoring and Supportive Care:**

1. **Monitor vital signs**: The patient's vital signs should be closely monitored, including heart rate, blood pressure, oxygen saturation, and respiratory rate.
2. **Monitor cardiac rhythm**: The patient's cardiac rhythm should be closely monitored for signs of arrhythmias or conduction abnormalities.
3. **Provide pain management**: The patient should be provided with pain management, including nitroglycerin and opioids, as needed.
4. **Provide emotional support**: The patient and their family should be provided with emotional support and counseling.

**Transfer to Intensive Care Unit (ICU):**

The patient should be transferred to the ICU for close monitoring and management of their condition.","{
  ""Score"": 1,
  ""Rationale"": ""The answer includes Acute Myocardial Infarction, which matches one of the rubric items. It does not include Takotsubo Cardiomyopathy or Unstable Angina, and the other diagnoses listed are not in the rubric.""
}","{""Score"":2,""Rationale"":""The answer correctly describes Acute Myocardial Infarction with elevated troponin and ST‑segment elevation, matching the rubric (2 points). It does not mention Takotsubo Cardiomyopathy, and the angina description does not align with the rubric’s Unstable Angina criteria, so no points for those items.""}","{""Score"":0,""Rationale"":""The answer does not mention any of the rubric's required opposing findings for Takotsubo cardiomyopathy, acute myocardial infarction, or unstable angina, and instead discusses unrelated diagnoses.""}","{""Score"":0,""Rationale"":""The response identifies the condition as Acute Myocardial Infarction (AMI) rather than the specific diagnosis required by the rubric, Acute Coronary Syndrome (Anterior STEMI). Since the answer does not match the rubric's key concept, no points are awarded.""}","{""Score"":2,""Rationale"":""The answer includes emotional support, matching the psychological support item (2 points). It does not mention follow‑up echocardiogram, referral to a cardiologist, or the full supportive care package (beta‑blockers + ACE inhibitors), so no points for those items.""}",5.0
"History of Present Illness
A 65-year-old male with a history of type 2 diabetes and hypertension presents with a 2-hour history of crushing chest pain radiating to his left arm. He describes the pain as severe and constant, beginning after he climbed a flight of stairs. He is also feeling nauseated and sweaty. He is unable to recall a prior history of similar symptoms. He denies shortness of breath or palpitations but admits to feeling unusually fatigued for the last week.

  Past Medical History
Type 2 diabetes mellitus for 15 years, hypertension for 12 years, and hyperlipidemia. He is on metformin and a statin. He has no history of coronary artery disease or previous myocardial infarctions. He is a smoker (30 pack-years) and drinks alcohol occasionally. Family history is significant for cardiovascular disease, with both parents having had myocardial infarctions in their 50s

  Physical Examination
VITALS: BP 160/90 mmHg, pulse 110 bpm, temperature 98.5°F. 
GEN: Anxious and diaphoretic, in moderate distress due to chest pain. 
CARDIAC: Tachycardic, regular rhythm
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender, no hepatosplenomegaly. 
MSK: No tenderness or joint swelling. 
EXT: No edema. 
SKIN: Diaphoretic, cool extremities.

  Laboratory Results
Troponin I: 3.2 ng/mL (elevated). CBC: Normal. Serum glucose: 180 mg/dL (elevated).",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, the following are three possible diagnoses:

1. **Acute Myocardial Infarction (AMI)**: The patient's symptoms of crushing chest pain radiating to the left arm, nausea, sweating, and elevated troponin levels are consistent with an AMI. The patient's history of type 2 diabetes, hypertension, and hyperlipidemia also increases his risk for coronary artery disease.

2. **Unstable Angina**: The patient's symptoms of chest pain and shortness of breath, along with his history of cardiovascular disease in his family, could be indicative of unstable angina. However, the elevated troponin levels suggest myocardial damage, which is more consistent with an AMI.

3. **Pulmonary Embolism (PE)**: Although the patient's physical examination is clear to auscultation bilaterally, the patient's symptoms of chest pain, shortness of breath, and elevated troponin levels could also be indicative of a PE. However, the absence of other symptoms such as dyspnea or tachypnea makes this diagnosis less likely.

It is essential to note that these diagnoses are not mutually exclusive, and further testing and evaluation may be necessary to determine the correct diagnosis.","Here are the findings and risk factors supporting each possible diagnosis:

**Acute Myocardial Infarction (AMI)**

1. **Symptoms**: The patient's symptoms of crushing chest pain radiating to the left arm, nausea, sweating, and fatigue are classic for an AMI.
2. **Elevated Troponin**: The patient's elevated troponin levels (3.2 ng/mL) indicate myocardial damage, which is a hallmark of an AMI.
3. **Risk Factors**: The patient has a history of type 2 diabetes, hypertension, and hyperlipidemia, which are all risk factors for coronary artery disease and AMI.
4. **Family History**: The patient's family history of cardiovascular disease, with both parents having had myocardial infarctions in their 50s, increases his risk for AMI.
5. **Physical Examination**: The patient's tachycardia, diaphoresis, and anxiety are all consistent with an AMI.

**Unstable Angina**

1. **Symptoms**: The patient's symptoms of chest pain and shortness of breath are consistent with unstable angina.
2. **Risk Factors**: The patient's history of type 2 diabetes, hypertension, and hyperlipidemia increases his risk for coronary artery disease and unstable angina.
3. **Family History**: The patient's family history of cardiovascular disease increases his risk for unstable angina.
4. **Physical Examination**: The patient's tachycardia and diaphoresis are consistent with unstable angina.

However, the elevated troponin levels suggest myocardial damage, which is more consistent with an AMI.

**Pulmonary Embolism (PE)**

1. **Risk Factors**: The patient's history of smoking (30 pack-years) increases his risk for deep vein thrombosis and PE.
2. **Physical Examination**: The patient's tachycardia and diaphoresis are consistent with a PE.
3. **Symptoms**: The patient's symptoms of chest pain and shortness of breath are consistent with a PE.
4. **Family History**: The patient's family history of cardiovascular disease does not directly increase his risk for PE.

However, the absence of other symptoms such as dyspnea or tachypnea makes this diagnosis less likely. Additionally, the patient's elevated troponin levels are more consistent with an AMI.","Here are the findings opposing each possible diagnosis:

**Acute Myocardial Infarction (AMI)**

1. **Expected but not present**: The patient's ECG is not mentioned, but it is expected to show signs of myocardial infarction such as ST-segment elevation or depression, Q-waves, or T-wave inversion. The absence of these findings would make the diagnosis of AMI less likely.
2. **Lack of typical ECG changes**: The patient's ECG is not mentioned, but it is expected to show signs of myocardial infarction such as ST-segment elevation or depression, Q-waves, or T-wave inversion. The absence of these findings would make the diagnosis of AMI less likely.
3. **Normal CBC**: The patient's CBC is normal, which is unexpected in the setting of an AMI, where anemia, leukocytosis, or thrombocytosis may be present.
4. **Normal serum glucose**: The patient's serum glucose is elevated, but it is not as high as expected in the setting of an AMI, where hyperglycemia is common due to stress and catecholamine release.

**Unstable Angina**

1. **Expected but not present**: The patient's ECG is not mentioned, but it is expected to show signs of ischemia such as ST-segment depression or T-wave inversion. The absence of these findings would make the diagnosis of unstable angina less likely.
2. **Lack of typical ECG changes**: The patient's ECG is not mentioned, but it is expected to show signs of ischemia such as ST-segment depression or T-wave inversion. The absence of these findings would make the diagnosis of unstable angina less likely.
3. **Normal troponin levels**: The patient's troponin levels are elevated, which is unexpected in the setting of unstable angina, where troponin levels are typically normal.
4. **No history of previous angina**: The patient has no history of previous angina, which is unexpected in the setting of unstable angina, where patients often have a history of stable angina.

**Pulmonary Embolism (PE)**

1. **Expected but not present**: The patient's chest X-ray is not mentioned, but it is expected to show signs of pulmonary embolism such as the Westermark sign or Hampton's hump. The absence of these findings would make the diagnosis of PE less likely.
2. **Lack of typical symptoms**: The patient's symptoms of chest pain and shortness of breath are not as severe as expected in the setting of a PE, where patients often experience severe dyspnea and chest pain.
3. **Normal D-dimer**: The patient's D-dimer is not mentioned, but it is expected to be elevated in the setting of a PE. The absence of an elevated D-dimer would make the diagnosis of PE less likely.
4. **No history of recent travel or surgery**: The patient has no history of recent travel or surgery, which is unexpected in the setting of a PE, where patients often have a history of recent travel or surgery.","Based on the patient's presentation, history, physical examination, and laboratory results, the final diagnosis is:

**Acute Myocardial Infarction (AMI)**

The patient's symptoms of crushing chest pain radiating to the left arm, nausea, sweating, and fatigue, along with his elevated troponin levels (3.2 ng/mL), are consistent with an AMI. The patient's history of type 2 diabetes, hypertension, and hyperlipidemia, as well as his family history of cardiovascular disease, increases his risk for coronary artery disease and AMI.

While the patient's ECG is not mentioned, it is expected to show signs of myocardial infarction such as ST-segment elevation or depression, Q-waves, or T-wave inversion. The absence of these findings would make the diagnosis of AMI less likely.

The patient's normal CBC and serum glucose levels are not typical of an AMI, but they do not rule out the diagnosis. The patient's elevated troponin levels and symptoms of chest pain and fatigue are more consistent with an AMI than with unstable angina or pulmonary embolism.

Therefore, based on the available information, the final diagnosis is Acute Myocardial Infarction (AMI).

**Treatment Plan**

The patient will be treated with:

1. **Aspirin**: To prevent further clot formation and reduce inflammation.
2. **Opioids**: To manage the patient's pain and discomfort.
3. **Beta-blockers**: To reduce the patient's heart rate and blood pressure.
4. **Nitroglycerin**: To reduce the patient's blood pressure and alleviate chest pain.
5. **Thrombolytic therapy**: To dissolve the clot causing the AMI.
6. **Cardiac catheterization**: To assess the extent of the AMI and determine the need for coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI).

The patient will be closely monitored in the intensive care unit (ICU) for any signs of complications, such as cardiac arrest, arrhythmias, or heart failure.","Based on the patient's diagnosis of Acute Myocardial Infarction (AMI), the following additional steps should be taken:

**Immediate Steps**

1. **Activate the cardiac catheterization laboratory**: To prepare for emergency coronary angiography and possible percutaneous coronary intervention (PCI).
2. **Administer thrombolytic therapy**: To dissolve the clot causing the AMI.
3. **Monitor the patient's vital signs**: To ensure that the patient's blood pressure, heart rate, and oxygen saturation are within normal limits.
4. **Administer oxygen**: To ensure that the patient is receiving adequate oxygenation.
5. **Monitor the patient's cardiac rhythm**: To ensure that the patient's heart rhythm is stable and not showing signs of arrhythmias.

**Additional Diagnostic Tests**

1. **Electrocardiogram (ECG)**: To confirm the diagnosis of AMI and assess the extent of myocardial damage.
2. **Cardiac biomarkers**: To assess the extent of myocardial damage and monitor the patient's response to treatment.
3. **Echocardiogram**: To assess the patient's left ventricular function and identify any signs of heart failure.
4. **Coronary angiography**: To assess the extent of coronary artery disease and determine the need for coronary artery bypass grafting (CABG) or PCI.

**Medications**

1. **Aspirin**: To prevent further clot formation and reduce inflammation.
2. **Beta-blockers**: To reduce the patient's heart rate and blood pressure.
3. **Nitroglycerin**: To reduce the patient's blood pressure and alleviate chest pain.
4. **Pain management**: To manage the patient's pain and discomfort.
5. **Anticoagulants**: To prevent further clot formation and reduce the risk of stroke.

**Monitoring and Follow-up**

1. **Monitor the patient's vital signs**: To ensure that the patient's blood pressure, heart rate, and oxygen saturation are within normal limits.
2. **Monitor the patient's cardiac rhythm**: To ensure that the patient's heart rhythm is stable and not showing signs of arrhythmias.
3. **Monitor the patient's cardiac biomarkers**: To assess the extent of myocardial damage and monitor the patient's response to treatment.
4. **Follow-up echocardiogram**: To assess the patient's left ventricular function and identify any signs of heart failure.
5. **Follow-up coronary angiography**: To assess the extent of coronary artery disease and determine the need for CABG or PCI.

**Discharge Planning**

1. **Discharge medications**: To ensure that the patient is taking the necessary medications to prevent further clot formation and reduce inflammation.
2. **Discharge instructions**: To educate the patient on the importance of taking their medications as directed and attending follow-up appointments.
3. **Follow-up appointments**: To schedule follow-up appointments with the patient's cardiologist and primary care physician to monitor the patient's progress and adjust treatment as needed.","{""Score"":2,""Rationale"":""The answer correctly includes Acute Myocardial Infarction and Unstable Angina, matching two rubric items. The third diagnosis (Pulmonary Embolism) does not match the required GERD, so only two points are awarded.""}","{""Score"":4,""Rationale"":""The answer correctly describes Acute Myocardial Infarction and Unstable Angina with the key symptoms, risk factors, and test findings listed in the rubric, earning 2 points each. However, it does not include the GERD diagnosis required by the rubric, resulting in a loss of the remaining 2 points.""}","{""Score"":0,""Rationale"":""The answer does not provide the opposing findings as described in the rubric for Acute MI, Unstable Angina, and GERD. It introduces Pulmonary Embolism, which is not part of the rubric, and fails to match any of the high‑scoring example concepts, so no points are awarded.""}","{""Score"":2,""Rationale"":""Student correctly identified Acute Myocardial Infarction with crushing chest pain, elevated troponin, and risk factors, matching the high scoring example.""}","{""Score"":4,""Rationale"":""The answer includes nitroglycerin and mentions cardiac catheterization/angiography, matching two rubric items (2 points each). It mentions aspirin but does not include heparin, so the first rubric item is not fully met. Total points awarded: 4 out of 6.""}",12.0
"History of Present Illness
A 60-year-old male with a recent history of hip replacement surgery 2 weeks ago presents with sudden onset of shortness of breath and pleuritic chest pain. The pain is sharp and worsens with deep breathing or coughing. He has been feeling progressively more breathless, even while at rest, and also reports a mild cough. He denies fever or hemoptysis but admits to feeling fatigued and dizzy on exertion. He has not been able to move around much post-surgery, and has been primarily confined to bed. He has no known history of deep vein thrombosis (DVT).

  Past Medical History
He has a history of osteoarthritis, for which he underwent the recent hip replacement. He has no known history of cardiovascular or respiratory disease. No significant family history of pulmonary embolism or clotting disorders. He is a non-smoker and does not drink alcohol.

  Physical Examination
VITALS: BP 130/85 mmHg, pulse 110 bpm, temperature 98.7°F, respiratory rate 22/min. GEN: Mildly anxious, appears in moderate distress due to breathing difficulties. CARDIAC: Tachycardic, regular rhythm, no murmurs. 
PULM: Tachypneic, decreased breath sounds at the right base, no wheezing. 
ABD: Soft, non-tender. 
MSK: Limited movement of the right hip due to recent surgery. 
EXT: Mild swelling in the right lower leg, no redness or warmth. 
SKIN: No rashes, warm extremities.

  Laboratory Results
D-dimer: 8.5 µg/mL (elevated). Chest CT angiogram: Acute pulmonary embolism in the right lower lobe pulmonary artery. ABG: pO2 70 mmHg, pCO2 35 mmHg.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's history and physical examination, the following are three possible diagnoses:

1. **Pulmonary Embolism (PE)**: The patient's sudden onset of shortness of breath, pleuritic chest pain, and elevated D-dimer levels are consistent with a pulmonary embolism. The chest CT angiogram confirms the diagnosis, showing an acute pulmonary embolism in the right lower lobe pulmonary artery.

2. **Deep Vein Thrombosis (DVT) with Pulmonary Embolism**: Although the patient denies a history of DVT, the mild swelling in the right lower leg and elevated D-dimer levels suggest the possibility of a DVT, which could have led to the pulmonary embolism.

3. **Postoperative Respiratory Compromise**: The patient's recent hip replacement surgery and prolonged bed rest may have contributed to respiratory compromise, including atelectasis, pneumonia, or pleural effusion, which could present with similar symptoms to pulmonary embolism.

However, the most likely diagnosis is **Pulmonary Embolism (PE)** given the patient's recent surgery, prolonged bed rest, and the presence of an acute pulmonary embolism on the chest CT angiogram.","Here are the findings and risk factors supporting each possible diagnosis:

**Pulmonary Embolism (PE)**

1. **Recent surgery**: The patient underwent hip replacement surgery 2 weeks ago, which is a known risk factor for developing DVT and subsequent PE.
2. **Prolonged bed rest**: The patient has been confined to bed for an extended period, increasing the risk of venous stasis and clot formation.
3. **Elevated D-dimer levels**: The patient's D-dimer level is elevated, which is a sensitive but non-specific marker for thrombosis.
4. **Chest CT angiogram findings**: The chest CT angiogram confirms the presence of an acute pulmonary embolism in the right lower lobe pulmonary artery.
5. **Symptoms**: The patient's sudden onset of shortness of breath, pleuritic chest pain, and tachypnea are consistent with a pulmonary embolism.

**Deep Vein Thrombosis (DVT) with Pulmonary Embolism**

1. **Mild swelling in the right lower leg**: The patient has mild swelling in the right lower leg, which could be indicative of a DVT.
2. **Elevated D-dimer levels**: Elevated D-dimer levels are consistent with both DVT and PE.
3. **Recent surgery**: The patient's recent surgery increases the risk of developing DVT and subsequent PE.
4. **Prolonged bed rest**: Prolonged bed rest increases the risk of venous stasis and clot formation, which could lead to DVT.

**Postoperative Respiratory Compromise**

1. **Recent surgery**: The patient's recent surgery may have led to respiratory compromise due to atelectasis, pneumonia, or pleural effusion.
2. **Prolonged bed rest**: Prolonged bed rest can lead to respiratory muscle weakness and atelectasis.
3. **Tachypnea**: The patient's tachypnea could be indicative of respiratory compromise.
4. **Decreased breath sounds at the right base**: Decreased breath sounds at the right base could be indicative of atelectasis or pleural effusion.

However, the presence of an acute pulmonary embolism on the chest CT angiogram and the patient's symptoms make **Pulmonary Embolism (PE)** the most likely diagnosis.","Here are the findings opposing each possible diagnosis:

**Pulmonary Embolism (PE)**

1. **Expected but not present: Fever**: Fever is a common symptom of pulmonary embolism, but the patient denies fever.
2. **Expected but not present: Hemoptysis**: Hemoptysis (coughing up blood) is a common symptom of pulmonary embolism, but the patient denies hemoptysis.
3. **Expected but not present: Tachycardia out of proportion to respiratory rate**: While the patient is tachycardic, the heart rate is not significantly elevated out of proportion to the respiratory rate, which is often seen in pulmonary embolism.
4. **Not expected: Mild swelling in the right lower leg**: While the patient has mild swelling in the right lower leg, this is not a typical finding in pulmonary embolism. DVT is a more likely explanation for this finding.
5. **Not expected: Limited movement of the right hip due to recent surgery**: The patient's limited movement of the right hip is due to recent surgery, but this is not a direct finding related to pulmonary embolism.

**Deep Vein Thrombosis (DVT) with Pulmonary Embolism**

1. **Expected but not present: Redness and warmth in the affected limb**: Redness and warmth are common signs of DVT, but the patient's right lower leg is only mildly swollen and has no redness or warmth.
2. **Expected but not present: Pain in the affected limb**: Pain in the affected limb is a common symptom of DVT, but the patient does not report pain in the right lower leg.
3. **Not expected: Elevated D-dimer levels without a clear source of thrombosis**: While the patient's D-dimer level is elevated, there is no clear source of thrombosis (e.g., recent surgery, trauma, or immobilization) that would explain the elevated D-dimer level.
4. **Not expected: Limited movement of the right hip due to recent surgery**: The patient's limited movement of the right hip is due to recent surgery, but this is not a direct finding related to DVT.

**Postoperative Respiratory Compromise**

1. **Expected but not present: Fever**: Fever is a common symptom of postoperative respiratory compromise, but the patient denies fever.
2. **Expected but not present: Cough with purulent sputum**: Cough with purulent sputum is a common symptom of postoperative pneumonia, but the patient does not report this symptom.
3. **Not expected: Elevated D-dimer levels**: Elevated D-dimer levels are not typically seen in postoperative respiratory compromise.
4. **Not expected: Acute pulmonary embolism on chest CT angiogram**: The presence of an acute pulmonary embolism on the chest CT angiogram makes postoperative respiratory compromise a less likely diagnosis.","Based on the patient's history, physical examination, laboratory results, and the findings supporting and opposing each possible diagnosis, the final diagnosis is:

**Pulmonary Embolism (PE)**

The patient's recent surgery, prolonged bed rest, and elevated D-dimer levels increase the risk of developing DVT and subsequent PE. The chest CT angiogram confirms the presence of an acute pulmonary embolism in the right lower lobe pulmonary artery. While the patient's symptoms and physical examination findings are consistent with PE, the absence of fever, hemoptysis, and tachycardia out of proportion to respiratory rate do not rule out this diagnosis. The presence of mild swelling in the right lower leg and limited movement of the right hip due to recent surgery may be related to DVT, but the primary diagnosis is PE.

**Treatment Plan**

1. **Anticoagulation therapy**: The patient will be started on anticoagulation therapy with low molecular weight heparin (LMWH) or unfractionated heparin (UFH) to prevent further clot formation and promote clot resolution.
2. **Pain management**: The patient will be managed with pain medication to alleviate symptoms of PE.
3. **Oxygen therapy**: The patient will be started on oxygen therapy to improve oxygen saturation.
4. **Monitoring**: The patient will be closely monitored for signs of complications, such as respiratory failure, cardiac arrest, or recurrent PE.
5. **Follow-up**: The patient will be followed up with a repeat chest CT angiogram in 1-2 weeks to assess for resolution of the PE and to determine the duration of anticoagulation therapy.

**Discharge Instructions**

1. **Anticoagulation therapy**: The patient will be discharged on anticoagulation therapy and will need to follow up with a healthcare provider for regular monitoring.
2. **Pain management**: The patient will need to continue pain medication as prescribed.
3. **Oxygen therapy**: The patient will need to continue oxygen therapy as prescribed.
4. **Follow-up**: The patient will need to follow up with a healthcare provider in 1-2 weeks for a repeat chest CT angiogram and to determine the duration of anticoagulation therapy.

**Prevention of Future Events**

1. **Early mobilization**: The patient will need to be encouraged to mobilize early to prevent further clot formation.
2. **Compression stockings**: The patient may be prescribed compression stockings to prevent DVT.
3. **Anticoagulation therapy**: The patient may need to continue anticoagulation therapy for an extended period to prevent recurrent PE.","Based on the patient's diagnosis of pulmonary embolism (PE), the following additional steps should be taken:

**Immediate Steps**

1. **Notify the patient's primary care physician**: Inform the patient's primary care physician about the diagnosis of PE and the treatment plan.
2. **Notify the patient's family members**: Inform the patient's family members about the diagnosis of PE and the treatment plan.
3. **Update the patient's medical record**: Update the patient's medical record with the diagnosis of PE and the treatment plan.

**Short-term Steps**

1. **Repeat chest CT angiogram**: Repeat the chest CT angiogram in 1-2 weeks to assess for resolution of the PE and to determine the duration of anticoagulation therapy.
2. **Monitor for complications**: Monitor the patient for signs of complications, such as respiratory failure, cardiac arrest, or recurrent PE.
3. **Adjust anticoagulation therapy**: Adjust the anticoagulation therapy as needed based on the patient's response to treatment and the results of the repeat chest CT angiogram.
4. **Monitor for bleeding**: Monitor the patient for signs of bleeding, such as bruising, petechiae, or hematuria.

**Long-term Steps**

1. **Risk factor modification**: Modify the patient's risk factors for PE, such as obesity, smoking, or family history of PE.
2. **Anticoagulation therapy**: Continue anticoagulation therapy for an extended period to prevent recurrent PE.
3. **Compression stockings**: Prescribe compression stockings to prevent DVT.
4. **Follow-up appointments**: Schedule follow-up appointments with the patient to monitor for signs of complications or recurrence of PE.

**Additional Testing**

1. **Echocardiogram**: Perform an echocardiogram to assess the patient's cardiac function and to evaluate for signs of right ventricular strain.
2. **D-dimer levels**: Repeat D-dimer levels to monitor for signs of recurrence of PE.
3. **Imaging studies**: Perform imaging studies, such as a ventilation-perfusion scan or a chest X-ray, to evaluate for signs of recurrence of PE.

**Patient Education**

1. **Anticoagulation therapy**: Educate the patient about the importance of anticoagulation therapy and the potential risks and benefits.
2. **Compression stockings**: Educate the patient about the importance of wearing compression stockings to prevent DVT.
3. **Risk factor modification**: Educate the patient about the importance of modifying their risk factors for PE.
4. **Follow-up appointments**: Educate the patient about the importance of following up with a healthcare provider for regular monitoring.","{""Score"":2,""Rationale"":""The answer includes Pulmonary Embolism and Deep Vein Thrombosis, which match two items in the rubric. The third listed diagnosis is 'Postoperative Respiratory Compromise' rather than the required 'Pneumonia', so only two points are awarded.""}","{""Score"":4,""Rationale"":""The answer includes all key points for Pulmonary Embolism and Deep Vein Thrombosis as listed in the rubric, earning 2 points each. It does not address Pneumonia or the criteria that make it less likely, so no points are awarded for that section.""}","{""Score"":2,""Rationale"":""Student correctly identified the lack of redness and warmth for DVT, matching the rubric; however, they listed opposing findings for PE and Pneumonia that contradict the rubric's statements, so no points for those sections.""}","{""Score"":2,""Rationale"":""Student correctly identified Pulmonary Embolism, noted elevated D-dimer and CT angiogram confirmation, matching the high scoring example.""}","{""Score"":0,""Rationale"":""The answer does not mention immediate initiation of anticoagulation, oxygen therapy, or ultrasound evaluation for DVT as required by the rubric; therefore no points are awarded.""}",10.0
"History of Present Illness
A 74-year-old female presents with a 1-month history of progressive fatigue, dizziness, and pale appearance. Over the last two weeks, she has noticed intermittent black, tarry stools and occasional bright red blood after bowel movements. She denies significant abdominal pain, nausea, or vomiting but mentions a history of occasional heartburn, which she manages with over-the-counter antacids. She has no history of hemorrhoids or significant gastrointestinal issues. She does not recall recent weight loss, but reports feeling more fatigued than usual.

  Past Medical History
She has a history of hypertension, controlled with an angiotensin II receptor blocker, and osteoarthritis. She is a former smoker (quit 10 years ago) and consumes alcohol occasionally. No family history of gastrointestinal cancers or bleeding disorders.

  Physical Examination
VITALS: BP 110/70 mmHg, pulse 88 bpm, temperature 98.2°F. 
GEN: Pale and fatigued-appearing. 
CARDIAC: Regular rhythm, no murmurs. 
PULM: Clear to auscultation bilaterally. 
ABD: Mild epigastric tenderness, no hepatosplenomegaly. No rebound tenderness or guarding. 
EXT: No edema, peripheral pulses intact. 
SKIN: Pale conjunctiva, no jaundice.

  Laboratory Results
Hemoglobin: 8.9 g/dL (low). Hematocrit: 27% (low). Platelets: 150 x 10^3/μL. Fecal occult blood test: Positive. Colonoscopy: Findings of multiple diverticula with no active bleeding. No masses or polyps observed.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are three possible diagnoses:

1. **Iron Deficiency Anemia (IDA)**: The patient's low hemoglobin and hematocrit levels, along with the presence of black, tarry stools (melena) and occasional bright red blood after bowel movements, are consistent with IDA. The fecal occult blood test is also positive, which supports this diagnosis.

2. **Diverticular Bleeding**: Although the colonoscopy did not show any active bleeding, the presence of multiple diverticula and the patient's symptoms of black, tarry stools and occasional bright red blood after bowel movements suggest that diverticular bleeding is a possible diagnosis.

3. **Gastrointestinal Bleeding due to Gastritis or Peptic Ulcer Disease**: The patient's history of occasional heartburn and the presence of mild epigastric tenderness on physical examination suggest that gastritis or peptic ulcer disease may be contributing to her symptoms. However, the colonoscopy did not show any masses or polyps, which makes this diagnosis less likely.

It's worth noting that the patient's age and sex, along with her symptoms and laboratory results, also make **Gastrointestinal Cancer** a possible diagnosis, although the colonoscopy did not show any masses or polyps. Further evaluation and follow-up may be necessary to rule out this diagnosis.","Here are the findings and risk factors that support each possible diagnosis:

**1. Iron Deficiency Anemia (IDA)**

* **Findings:**
 + Low hemoglobin and hematocrit levels (8.9 g/dL and 27%, respectively)
 + Positive fecal occult blood test
 + Black, tarry stools (melena) and occasional bright red blood after bowel movements
* **Risk Factors:**
 + Age: IDA is more common in older adults
 + Sex: Women are more likely to develop IDA due to menstrual blood loss
 + History of gastrointestinal bleeding or surgery
 + Poor diet or malabsorption of iron
 + Chronic diseases such as celiac disease or Crohn's disease

**2. Diverticular Bleeding**

* **Findings:**
 + Presence of multiple diverticula on colonoscopy
 + Black, tarry stools (melena) and occasional bright red blood after bowel movements
 + No masses or polyps observed on colonoscopy
* **Risk Factors:**
 + Age: Diverticular disease is more common in older adults
 + Sex: Men are more likely to develop diverticular disease
 + History of constipation or low-fiber diet
 + Family history of diverticular disease
 + Presence of other comorbidities such as hypertension or diabetes

**3. Gastrointestinal Bleeding due to Gastritis or Peptic Ulcer Disease**

* **Findings:**
 + History of occasional heartburn
 + Mild epigastric tenderness on physical examination
 + No masses or polyps observed on colonoscopy
* **Risk Factors:**
 + Age: Gastritis and peptic ulcer disease are more common in older adults
 + Sex: Men are more likely to develop peptic ulcer disease
 + History of smoking or alcohol use
 + Use of nonsteroidal anti-inflammatory drugs (NSAIDs)
 + Presence of other comorbidities such as Helicobacter pylori infection

**4. Gastrointestinal Cancer**

* **Findings:**
 + Age: Gastrointestinal cancer is more common in older adults
 + Sex: Men are more likely to develop gastrointestinal cancer
 + History of smoking or alcohol use
 + Presence of other comorbidities such as obesity or diabetes
 + No masses or polyps observed on colonoscopy (although this does not rule out cancer)
* **Risk Factors:**
 + Family history of gastrointestinal cancer
 + History of inflammatory bowel disease (IBD)
 + Presence of genetic syndromes such as Lynch syndrome or familial adenomatous polyposis (FAP)

It's worth noting that the patient's age and sex, along with her symptoms and laboratory results, make gastrointestinal cancer a possible diagnosis, although the colonoscopy did not show any masses or polyps. Further evaluation and follow-up may be necessary to rule out this diagnosis.","Here are the findings that oppose each possible diagnosis:

**1. Iron Deficiency Anemia (IDA)**

* **Findings opposing this hypothesis:**
 + **Normal hemoglobin and hematocrit levels**: If the patient's anemia was due to a cause other than IDA, such as chronic disease or kidney disease, her hemoglobin and hematocrit levels may be normal or elevated.
 + **No gastrointestinal bleeding**: If the patient's anemia was not due to gastrointestinal bleeding, her fecal occult blood test may be negative, and she may not have black, tarry stools or bright red blood after bowel movements.
 + **No evidence of malabsorption**: If the patient's anemia was not due to malabsorption of iron, her diet and nutritional status may be normal, and she may not have any other symptoms of malabsorption.
* **Findings that were expected but not present:**
 + **Higher ferritin levels**: If the patient's anemia was due to IDA, her ferritin levels would be expected to be low. However, ferritin levels were not mentioned in the patient's laboratory results.
 + **Evidence of iron deficiency on colonoscopy**: If the patient's anemia was due to IDA, the colonoscopy may have shown evidence of iron deficiency, such as atrophic gastritis or small bowel mucosal changes.

**2. Diverticular Bleeding**

* **Findings opposing this hypothesis:**
 + **No active bleeding on colonoscopy**: If the patient's bleeding was not due to diverticular disease, the colonoscopy may have shown no evidence of active bleeding.
 + **No diverticula on colonoscopy**: If the patient's bleeding was not due to diverticular disease, the colonoscopy may have shown no evidence of diverticula.
 + **No history of constipation or low-fiber diet**: If the patient's bleeding was not due to diverticular disease, she may not have a history of constipation or low-fiber diet.
* **Findings that were expected but not present:**
 + **Evidence of diverticulosis on colonoscopy**: If the patient's bleeding was due to diverticular disease, the colonoscopy would be expected to show evidence of diverticulosis, such as multiple diverticula.
 + **History of diverticular disease**: If the patient's bleeding was due to diverticular disease, she may have a history of diverticular disease.

**3. Gastrointestinal Bleeding due to Gastritis or Peptic Ulcer Disease**

* **Findings opposing this hypothesis:**
 + **No evidence of gastritis or peptic ulcer disease on endoscopy**: If the patient's bleeding was not due to gastritis or peptic ulcer disease, the endoscopy may have shown no evidence of gastritis or peptic ulcer disease.
 + **No history of NSAID use**: If the patient's bleeding was not due to gastritis or peptic ulcer disease, she may not have a history of NSAID use.
 + **No evidence of Helicobacter pylori infection**: If the patient's bleeding was not due to gastritis or peptic ulcer disease, she may not have evidence of Helicobacter pylori infection.
* **Findings that were expected but not present:**
 + **Evidence of gastritis or peptic ulcer disease on endoscopy**: If the patient's bleeding was due to gastritis or peptic ulcer disease, the endoscopy would be expected to show evidence of gastritis or peptic ulcer disease.
 + **History of smoking or alcohol use**: If the patient's bleeding was due to gastritis or peptic ulcer disease, she may have a history of smoking or alcohol use.

**4. Gastrointestinal Cancer**

* **Findings opposing this hypothesis:**
 + **No masses or polyps on colonoscopy**: If the patient's bleeding was not due to gastrointestinal cancer, the colonoscopy may have shown no evidence of masses or polyps.
 + **No family history of gastrointestinal cancer**: If the patient's bleeding was not due to gastrointestinal cancer, she may not have a family history of gastrointestinal cancer.
 + **No history of inflammatory bowel disease (IBD)**: If the patient's bleeding was not due to gastrointestinal cancer, she may not have a history of IBD.
* **Findings that were expected but not present:**
 + **Evidence of cancer on colonoscopy**: If the patient's bleeding was due to gastrointestinal cancer, the colonoscopy would be expected to show evidence of cancer, such as a mass or polyp.
 + **History of smoking or alcohol use**: If the patient's bleeding was due to gastrointestinal cancer, she may have a history of smoking or alcohol use.","Based on the patient's symptoms, laboratory results, and physical examination, I would make the following final diagnosis:

**Iron Deficiency Anemia (IDA)**

The patient's low hemoglobin and hematocrit levels, along with the presence of black, tarry stools (melena) and occasional bright red blood after bowel movements, are consistent with IDA. The fecal occult blood test is also positive, which supports this diagnosis. The colonoscopy did not show any masses or polyps, but it did show multiple diverticula, which may be contributing to the patient's bleeding.

The patient's history of occasional heartburn and mild epigastric tenderness on physical examination may suggest gastritis or peptic ulcer disease, but the colonoscopy did not show any evidence of these conditions. The patient's age and sex, along with her symptoms and laboratory results, make gastrointestinal cancer a possible diagnosis, but the colonoscopy did not show any masses or polyps, and there is no family history of gastrointestinal cancer.

The patient's diverticulosis may be contributing to her bleeding, but the colonoscopy did not show any evidence of active bleeding, and the patient's symptoms are more consistent with IDA.

Therefore, the final diagnosis is Iron Deficiency Anemia (IDA), with possible contributing factors including diverticulosis and gastritis or peptic ulcer disease.

**Treatment Plan:**

1. Iron supplementation: The patient will be started on iron supplements to correct her iron deficiency anemia.
2. Colonoscopy follow-up: The patient will be scheduled for a follow-up colonoscopy in 6-12 months to monitor her diverticulosis and rule out any new polyps or masses.
3. Gastritis or peptic ulcer disease treatment: The patient will be treated for gastritis or peptic ulcer disease with medications such as proton pump inhibitors (PPIs) or histamine-2 (H2) blockers.
4. Dietary changes: The patient will be advised to make dietary changes to increase her iron intake and reduce her risk of bleeding.

**Follow-up:**

The patient will be followed up in 6-12 months to monitor her response to treatment and to rule out any new polyps or masses.","Based on the final diagnosis of Iron Deficiency Anemia (IDA) and the possible contributing factors of diverticulosis and gastritis or peptic ulcer disease, the following additional steps can be taken:

**Additional Diagnostic Tests:**

1. **Ferritin levels**: To confirm the diagnosis of IDA, ferritin levels should be measured to assess the patient's iron stores.
2. **Complete Blood Count (CBC)**: A CBC will be repeated to monitor the patient's hemoglobin and hematocrit levels.
3. **Endoscopy**: An upper endoscopy may be performed to evaluate the patient's esophagus, stomach, and duodenum for signs of gastritis or peptic ulcer disease.
4. **Helicobacter pylori (H. pylori) testing**: The patient may be tested for H. pylori infection, which is a common cause of gastritis and peptic ulcer disease.

**Additional Treatment Steps:**

1. **Iron supplementation**: The patient will be started on iron supplements to correct her iron deficiency anemia.
2. **Proton pump inhibitors (PPIs) or histamine-2 (H2) blockers**: The patient will be treated with PPIs or H2 blockers to reduce stomach acid and promote healing of the stomach lining.
3. **Antibiotics**: If the patient is found to have H. pylori infection, antibiotics will be prescribed to treat the infection.
4. **Dietary changes**: The patient will be advised to make dietary changes to increase her iron intake and reduce her risk of bleeding.

**Additional Preventive Measures:**

1. **Regular follow-up**: The patient will be scheduled for regular follow-up appointments to monitor her response to treatment and to rule out any new polyps or masses.
2. **Colonoscopy screening**: The patient will be advised to undergo regular colonoscopy screening to monitor her diverticulosis and rule out any new polyps or masses.
3. **Lifestyle modifications**: The patient will be advised to make lifestyle modifications to reduce her risk of bleeding, such as avoiding NSAIDs, quitting smoking, and reducing her alcohol intake.

**Additional Considerations:**

1. **Vitamin B12 deficiency**: The patient may be at risk for vitamin B12 deficiency due to her IDA. Vitamin B12 levels should be measured and supplementation may be necessary.
2. **Folate deficiency**: The patient may be at risk for folate deficiency due to her IDA. Folate levels should be measured and supplementation may be necessary.
3. **Anemia management**: The patient will be managed for anemia with regular blood counts and iron supplementation as needed.

By taking these additional steps, the patient's IDA can be effectively managed, and her risk of bleeding can be reduced.","{""Score"":3,""Rationale"":""The answer includes Peptic Ulcer Disease with GI bleeding, Gastritis with GI bleeding, and Gastrointestinal Malignancy, matching all three items in the rubric.""}","{
  ""Score"": 0,
  ""Rationale"": ""The student's answer does not match the specific concepts listed in the rubric for any of the three high-scoring diagnoses. Key rubric elements such as chronic antacid use, slow progressive anemia, lack of massive hemorrhage, and absence of weight loss or abdominal mass are missing, resulting in no points awarded.""
}","{""Score"":4,""Rationale"":""Student identified 'No history of NSAID use' (matches PUD) and 'No masses or polyps on colonoscopy' (matches normal colonoscopy for malignancy). Did not provide the required 'No endoscopic confirmation yet' for gastritis/chronic GI bleeding, thus earns 4 of 6 points.""}","{""Score"":2,""Rationale"":""Student included melena, anemia, positive fecal occult blood test, heartburn, and noted absence of active lower GI bleeding on colonoscopy, matching all concepts in the high‑scoring example.""}","{""Score"":6,""Rationale"":""The answer includes an upper endoscopy, PPI therapy, monitoring of hemoglobin levels, and assessment/treatment for Helicobacter pylori, matching all four rubric items.""}",15.0
,,,,,,,,,,,,,,,,
